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CHAPTER I 
ANDRASTINS 
 
1.1 Introduction 
 
Meroterpenoids are a subclass of terpenoids which are derived from mixed biosynthetic 
origin. These natural products are most often isolated from fungi and marine organisms, 
but higher plants can also produce meroterpenoids. In addition to their wide occurrence, 
meroterpenoids display a huge range of structural diversity. Moreover, they include 
remarkable biologically active compounds, such as the acetylcholinesterase inhibitors 
arisugacins (1, 2) and territrems (3, 4), the immunosuppressive agent mycophenolic acid 
(5), the anti-tumor agent eupenifeldin (6), the protein farnesyltransferase inhibitor 
andrastins (7-10) and so on (Figure 1). 1	  
Figure 1. Meroterpenoids isolated from fungi 
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Andrastins were originally isolated from a cultured broth of Penicillium sp. FO-3929 by 
S. Omura and co-workers in 1996.2-5 They are also produced by several other 
Penicillium species.6 Biological experiments showed that andrastins inhibit the protein 
farnesyltransferase (PFTase) in the µM level (IC50 = 13.3 ~ 47.1 µM),4 therefore, they 
are expected to be promising leads for anticancer drugs, since farnesylation of the ras 
oncogene protein is essential for its function. The structures of andrastins have been 
elucidated by NMR and X-ray crystallographic analysis. The core structure of 
andrastins are consisted of four fused rings with trans-trans-cis fusion. Notably, the 
cis-fused CD ring juncture possesses two vicinal quaternary carbons. 
 
Figure 2. Docking mode between PFTase and andrastins 
 
The interaction between PFTase and andrastins has been demonstrated by G. Vistoli et 
al. based on the detailed docking analysis.7 The two most active compounds (andrastin 
A and andrastin C) form an ion pair between carboxyl group and Zn2+ ion. This 
electrostatic interaction has been thought to be essential for the inhibition activity. The 
hydrogen bonds concur to stabilize the PFTase–andrastin complex. In fact, andrastin A 
and C realize three hydrogen bonds that involve the acetoxyl group, the carboxyl moiety, 
and the hydroxyl group with Cys-95β, Tyr-300β, and Ser-357β, respectively (Figure 2). 
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These results especially underlie the importance of highly functionalized fused-CD ring 
system. In consideration of their structural complexity coupled with potent biological 
properties, great attentions have been attracted from the biosynthetic and chemical 
synthetic community. 
 
1.2 Biosynthesis 
 
 
Scheme 1. Proposed biosynthesis pathway of andrastins 
 
In 2013, I. Abe and co-workers reported the biosynthesis pathway of andrastin A 
(Scheme 1).8 The epoxyfarnesyl-DMOA methyl ester (11) is believed to be a common 
intermediate, which is further converted into different polycyclic scaffolds. Proton 
abstraction from C-11 in intermediate 12, and subsequent carbon skeletal rearrangement 
yields 13. Oxidation of the α-alcohol 13 gives the ketone andrastin D (10). Since the 
acetoxy group in andrastin A-C (7-9) is C-3β, the C-3 ketone would then be reduced to 
a C-3β hydroxyl group in compound 14. Finally, a cytochrome P450 monooxygenase is 
OH
CO2Me
O
O
epoxyfarnesyl-DMOA methyl ester
HO
H
HMe Me
H
O
OH
CO2Me
andrastin D (10)
andrastin A (7)andrastin B (8)
andrastin C (9)
11
11
12 13
14
O
Me
OH
Me
Me
H
MeMe
H
Me Me
CO2MeHO
O
Me
OH
Me
Me
H
MeMe
H
Me Me
CO2MeO
O
Me
OH
Me
Me
H
MeMe
H
Me Me
CO2MeHO
O
Me
OH
Me
Me
H
MeMe
H
Me Me
CO2MeAcO
O
Me
OH
Me
Me
H
Me
H
Me Me
CO2MeAcO
HO
O
Me
OH
Me
Me
H
Me
H
Me Me
CO2MeAcO
O
 7 
predicted to catalyze the consecutive oxidations of the C-23 methyl group to afford 
andrastin B (8) and andrastin A (7). 9 
 
1.3 Syntheses 
 
The first synthetic studies toward andrastin C were undertaken in the group of M. 
Toyota.10 Their synthesis commenced with preparation of trans-decalin 16 from 
Wieland-Miescher ketone 15 through an established method. After ring opening and 
functional group manipulation, the intramolecular Diels-Alder reaction precursor 17 
was produced, which was heated to 230 °C in toluene in a stainless autoclave gave rise 
to the desired cycloadduct 18 as a single diastereoisomer. Then elaboration of the 
C-ring of 18 transformed to the aldehyde 19, and the intramolecular carbonyl ene 
reaction turned out to be effective to provide the cyclization product 20 in 95% yield 
possessing vicinal quaternary carbons. Oxidation of the secondary alcohol and reductive 
removal of the alkoxy group in ring D yielded the highly functionalized 20 (Scheme 2). 
Scheme 2. Toyota’s work toward synthesis of andrastin C 
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1.4 Overview of This Work 
 
Due to their fascinating structural features and potential medicinal applications, I have 
become interested in the total synthetic study towards andrastins. Although a wide 
variety of procedures for the synthesis of angularly substituted hydrindanes have been 
reported by means of transition metal catalyzed cyclization,11 radical cyclizations,12 
carbene reactions,13 and intramolecular Hosomi–Sakurai reactions.14 The construction 
of angularly substituted cis-hydrindanes is still a challenging field. As a key structure 
feature and main pharmacophore, I started my work from construction of angularly 
cis-fused CD ring fragment, in which the Diels-Alder reaction was conceived as the 
synthetic strategy.  
 
In Chapter II, I examined the intramolecular Diels-Alder reaction of 47 for synthesis of 
highly congested cis-hydrindane, which led to the tricyclic lactone 48 containing CD 
ring fragment efficiently. This method was then expanded to construct the more 
advanced BCD fragment 54a. 
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III, a Diels-Alder substrate 70 was synthesized from known Wieland-Miescher ketone. 
Unfortunately, it did not undergo cyclization to achieve pentacyclic lactone 71.  
 
In Chapter IV, after careful considerations, I revised the Diels-Alder substrate to 73 
similar to the substrate in the BCD ring formation, which ultimately led to key skeleton 
of andrastins 72.  
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CHAPTER II 
SYNTHESIS OF THE BCD RING FRAGMENT  
 
2.1 Synthesis Towards D-ring Fragment  
 
The Diels-Alder reaction occupies a special position among organic reactions due to its 
ability to convert relatively simple starting materials into highly complex molecular 
frameworks in a single step. Recognizing the reaction’s potential, synthetic organic 
chemists have invested significant effort developing and applying a seemingly endless 
array of useful variations of the Diels-Alder reaction in the syntheses of natural products 
such as terpenes, alkaloids and steroids.15 
I also become interested in construction of the sterically hindered cis-fused CD ring of 
andrastins using the inter- or intramolecular Diels-Alder reaction. If the appropriate 
diene and dienophile could be designed, the complex CD ring fragment may be 
constructed efficiently. After careful discussion and consideration, 21 or its derivatives 
(Scheme 3), containing all of the functional group of D-ring, has been chosen as a 
synthetic target to act as a dienophile part. 
Scheme 3. Approach for the synthesis of D ring fragment  
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rearrangement is believed to involve formation of a zwitterionic acylium-enolate that 
rapidly cyclizes. 
 Scheme 4. Mechanism of the Moore reaction 
 
My synthesis commenced with the synthesis of vinyl benzoquinone 27 (Scheme 5). 
Bromination of 2,5-dimethylphenol 23 in the presence of aluminium powder and Br2 
furnished tribromophenol 24 in 88% yield. Then nitration of 24 with fuming nitric acid 
in acetic acid gave 2,5-dienone 25, which was treated with carbon tetrachloride at 10 °C 
yielded 26.17 In order to introduce the carbonyl group in 21, a vinyl substituent was 
selected which could be oxidatively cleaved to aldehyde. Coupling reaction of 26 with 
equal equivalent of tributylvinyltin through a Stille condition [Pd2(dba)3·CHCl3−AsPh3] 
furnished 27 in 89% yield.18 
Scheme 5. Preparation of benzoquinone 27 
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may be because of conjugate addition of the azide onto the vinyl group. Then 
elaboration of the vinyl group was considered, and combinations of RuO2-Oxone,19 
RuCl3-Oxone,20 and OsO4-NMO have been tried. Disappointingly, neither aldehyde 29 
nor dihydroxyl product 30 could be detected. 
Scheme 6. Attempts on azidation or vinyl oxidation of 27 
 
 
 
Scheme 7. Synthesis of 1,3-dione 33 and attempts on oxidation  
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be problematic, both metal-catalyzed conditions (RuO4, OsO4) and ozonolysis resulted 
in decomposition of 33, which may be attributed to the inherent instability of the 
tricarbonyl cyclopentene 34 (Scheme 7). 
Scheme 8. Synthesis of 1,3-dione 37 and attempts on oxidation 
 
The furan ring can be oxidized to the corresponding carboxylic acid by the action of 
ozone or ruthenium tetroxide.21 I then replace the styryl group into a furan moiety which 
can be converted to the carboxylic acid directly. Treatment of the benzoquinone 26 with 
(2-furyl)tributyltin under the condition of Pd2(dba)3·CHCl3 and AsPh3 furnished 35 in 
96% yield. Then substitution of the bromo group with azide, followed by heating at 
110 °C yielded the ring contracted 1,3-dione 36 in 21% yield over two steps. Treatment 
of 36 with concentrated HCl solution afforded 37 in 30% yield (Scheme 8). At last, 
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2.2 Synthesis of Cyclopentenone 43  
 
Having realized the difficulty in the synthesis of fully functionalized D-ring fragment, I 
turned to simplified D-ring such as 42 or 43 which would be decorated to the 1,3-dione 
in the late stage of the synthesis. 
The preparation of dienophile methyl carboxylate 43 (Scheme 9) started from 
commercially available 2-methylcyclopentane-1,3-dione 38, which was transformed to 
the corresponding ethyl enol ether 39 in 91% yield, by using ethyl orthoformate in the 
presence of H2SO4.22 Then 39 was converted to the 3-formylcycloalkenone 41 using a 
two-step reaction sequence.23 Treatment of 39 with freshly prepared 
bis(methylthio)methyllithium, followed by acidification gave rise to the adduct 40 
which was efficiently hydrolyzed to the aldehyde 41 using MeI in high yield over two 
steps. Aldehyde 41 was oxidized to the carboxylic acid 42 through Pinnick oxidation, 
and the dienophile 43 was produced by the general condensation condition with 
methanol.  
Scheme 9. Synthesis of dienophile 42 and 43 
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2.3 Intermolecular Diels-Alder Reaction for the Synthesis of 45  
 
Methyl 2-methylcyclopenten-3-one-1-carboxylate (43) is considered as a highly 
activated dienophile for Diels-Alder reaction. However, this compound has never been 
used as a Diels-Alder dienophile with unactivated dienes probably due to steric 
congestion, although several examples have been reported that similar tetra-substituted 
cyclopentenone derivatives are conducted to intermolecular Diels-Alder reaction with 
dienes activated by one or more alkoxy substituents.24 In regard to the cycloaddition 
reaction of the compound 43, photochemical [2+2] addition with allenes is only one 
example to the best of our knowledge.25 
 
Table 1. Intermolecular Diels-Alder reaction between diene 44 and dienophile 43 
 
Houk et al. have recently reported the intermolecular Diels-Alder reaction between 
1,3-hexadiene and cyclobutenone or cyclopentenone which selectively afforded the 
endo product.26 I also investigated the Diels-Alder reaction for the synthesis of cis-fused 
CD ring of andrastins (Table 1). The reaction did not proceed in toluene at reflux 
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AlCl3 (1.0 eq)
BF3•OEt2 (0.2 eq) 110 24 no reaction
no reaction
2 BHT (5 mol%) reflux 24 no reaction
6
r.t. 12
AlCl3 (1.0 eq) no reaction110 24
toluene
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condition without any additive or at the presence of antioxidant BHT (entry 1, 2). Then 
Lewis acid catalyzed conditions were attempted, and BF3·OEt2 was firstly chosen as the 
catalyst. However, the reaction did not give any cycloadducts at room temperature, or 
even at 110 °C condition (entry 3, 4). At last, AlCl3 promoted cycloaddition was 
attempted, but also gave no products (entry 5, 6). The dienophile 43 was found to be 
inert to the above vigorous Diles-Alder conditions, which have proved the hypothesis 
that it is reluctant to react with unactivated dienes. 
 
2.4 Synthesis of CD Fragment by Intramolecular Diels-Alder Reaction   
 
Scheme 10. Successful Diels-Alder reaction for CD fragment 
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correlation experiments (Scheme 10).  
 
2.5 Synthesis of BCD Ring Fragment 
 
Encouraged by the above results, I applied this strategy for the construction of the 
steroidal BCD ring system of andrastins with cis-hydrindane framework. The 
Diels-Alder substrate 53 was designed for this purpose, and synthesized according to 
Scheme 11. Commercially available cyclohexanedione 49 was converted to the 
iso-butyl enol ether 50 following the literature method,27 and the product 50 was 
allowed to react with trans-propenyl Grignard reagent followed by acidic hydrolysis to 
afford the dienone 51 in good yield. DIBAL reduction of 51 gave the alcohol 52, which 
was subjected to esterification with carboxylic acid 42 using EDCI and DMAP to 
furnish the Diels-Alder substrate 53 in an efficient manner. 
 
Scheme 11. Preparation of a Diels-Alder substrate 53 
 
With the substrate compound 53 in hand, I investigated optimal conditions for the 
intramolecular Diels-Alder reaction to establish the lactone-tethered tricyclic system 
formation (Table 2). Although the reaction did not proceed under toluene reflux 
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condition (entry 1), the desired cycloadducts were formed in refluxing xylene in low 
yield (entry 2). Favorably the reaction was largely improved at 145 °C in a sealed tube 
to realize 73% yield, whose endo/exo ratio was 53/20 (entry 3). The reaction was found 
to be highly susceptible to the temperature, and the yield was decreased at 160 °C (entry 
4) and considerable decomposition was observed in short time at 180 °C in 
o-dichlorobenzene (entry 5).  
 
Table 2. Diels–Alder Reaction for steroidal BCD ring with cis-hydrindane framework 
 
  
Figure 3. ORTEP drawing of the endo adduct 54a 
 
The stereochemisrty of the product 54a was unambiguously determined by X-ray 
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14
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18
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no reaction
17 / 19
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complex mixture
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crystallography (Figure 3) to be an endo adduct, which was predominant product via 
the similar endo transition state in the case of Scheme 10. Thus, the best condition of 
the intramolecular Diels-Alder reaction of 53 was established, and efficient approach for 
the tetracyclic framework 54 including the BCD ring fragment and the ester tether was 
accomplished.  
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CHAPTER III 
SYNTHETIC STUDY TOWARDS ANDRATINS (1) 
 
3.1 Retrosynthetic Analysis of Andrastin C  
 
 
Scheme 12. Retrosynthetic analysis of andrastin C 
 
Inspired by the result that intramolecular Diels-Alder reaction provided a powerful 
method for the synthesis of angularly cis-hydrindane which led to the formation of CD 
and BCD ring fragment of andrastins, construction of the tetracyclic framework of 
andrastins was attempted. My strategy is outlined in Scheme 12. 
At first glance, a pentacyclic lactone 55 which was envisaged to be accessed from the 
ester 56 through intramolecular Diels-Alder reaction, would convert to andrastin C via a 
sequence of seemingly simple operations. And the key Diels-Alder precursor 56 could 
be furnished by an esterification of the dienyl alcohol 57 with carboxylic acid 42. 
55
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O
Wieland-Miescher ketone
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Introduction of a propenyl group followed by a reduction of the methyl ester on 58 
could lead to 57. The β-ketoester 58 would be constructed from 59 through 
stereoselective reduction of the ketone on the A-ring and then methoxycarbonyl 
introduction at the α-position of the remaining ketal group. The decalin framework 59 
could be derived from Wieland-Miescher ketone 15 via several functionalizations. 
Optically active 15 has been employed as a key starting material for the total syntheses 
of a variety of terpenoids and steroids. 
 
3.2 Synthesis of β-Ketoester 58 
 
 Scheme 13. Synthesis of the ketone 59 
 
According to the protocol described by Harada et al., the prochiral triketone 61 was 
prepared from 2-methyl-1,3-cyclohexanedione 60 and methyl vinyl ketone in the 
presence of hydroquinone. A solution of 61 and unnatural D-(+)-proline (10 mol%) in 
DMSO was stirred at room temperature for 4 days to furnish the Wieland-Miescher 
O
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(15)   e.e. > 99%
Me
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80% O
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H
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O
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ketone 60 (Scheme 13).28 After recrystallization the e.e. value could be up to 99%. 
Treatment of 15 with a stoichiometric amount of PTSA selectively provided the C9 
ketalization product 62 in 80% yield.29 Among a variety of reported approaches for the 
constructing a trans-decalone 59, I adopted a convenient Kire-Petrow 
(phenylthio)methylation protocol.30 Although this transformation is inherently slow, 
treatment of 63 with thiophenol and formaldehyde for 4 days gave 63 in 84% yield. The 
required tans-decalin stereochemistry was next achieved by Birch reduction of 63, 
employing the intermediacy of lithium enolate, which was methylated by MeI to give 
the corresponding trans-decalone 59.31  
 
 
Scheme 14. Synthesis of the β-ketoester 58 
 
As reported by K. Kawada et al., L-Selectride reduction of 59 selectively afforded the 
C-3 axial alcohol 64 in 98% yield. Then deprotection of the ketal group in 64, followed 
by protection of the C-3 hydroxyl group of 65 with TBSCl yielded the ketone 66.32 A 
methoxycarbonyl group was then installed adjacent to the carbonyl group in 66 by using 
LDA and NCCO2Me to give β-ketoester 58 in 92% yield (Scheme 14).33 
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3.3 Preparation of Diels-Alder Substrate 70 
 
Then O-triflation of the β-ketoester 58 with NaH and Tf2O provided the alkenyl triflate 
67 in quantitative yield (Scheme 15). Next, the triflate 67 was subjected to the 
Pd-catalyzed coupling reaction with tributylvinyltin in THF under reflux to provide the 
dienyl methyl ester 68 in excellent yield,34 a vinyl group instead of a propenyl group 
was introduced for simplicity of operation. Reduction of the methoxycarbonyl group in 
68 with DIBAL furnished 69, which was condensed with carboxylic acid 42 to give the 
Diels-Alder precursor 70. 
Scheme 15. Synthesis of the Diels-Alder precursor 70 
 
3.4 Attempts on Diels-Alder Reaction of 70 
 
With the ester-tethered Diels-Alder precursor 70 in hand, I ultimately wanted it to 
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undergo cyclization to achieve the desired pentacyclic lactone 71. Thermal-promoted 
Diels-Alder conditions were first examined (Table 3, entry 1–5). The ester 70 was 
heated in various solvents that had stable heating profiles and good solubility with the 
substrate. However, none of the runs furnished the lactone 71. The substrate 70 showed 
so unimaginable stability that it was reluctant to react even at 180 °C. Since the thermal 
methods did not afford any of the cyclized product, we decided switch to the Lewis 
acid-promoted conditions (entry 6–11). Subjection of substrate 70 in the presence of 
various Lewis acid at low temperature, once again no cyclization was seen. 
Table 3. Diels-Alder conditions for the preparation of 71 
 
When comparing the substrate 70 with 47 and 53, which underwent the Diels-Alder 
reaction to give the cycloadduct 48, 54, respectively, the compound 70 seemed to be 
70 71
1
2
4
toluene 0.05 120 12 no reaction
xylene 0.02 147 96
DMF 0.02 180 72
5 o-DCB 0.02 180 72
almost no reaction
almost no reaction
almost no reaction
Entry Solvent Temp. (˚C) Time (h)Conc. (M) Result
6
7
8
9
0.01 0 ! r.t. 1 complex mixture
0.1 0 ! r.t. 1 complex mixture
toluene 0.05 –78 ! r.t. 12
0.05 –78 ! r.t. 12
10 0.02 12
complex mixture
complex mixture
complex mixture
Lewis acid
AlCl3
ZnCl2
EtAlCl2
SnCl4 CH2Cl2 –78 ! r.t.
11 TiCl4 CH2Cl2 0.02 –78 ! r.t. 12 complex mixture
CH2Cl2
CH2Cl2
CH2Cl2
BF3•OEt2
3 toluene 0.02 180 24 almost no reaction
 Entries (1–5) were conducted in a sealed tube.
Me
H
Me Me
TBSO
Me O
O
O
Me
H
Me Me
TBSO
O O
Me
O
conditions
 25 
suffered from great steric congestion due to the (E)-configuration of the diene, which 
had been believed to cyclize more slowly than the corresponding (Z)-diene.35 The 
thermally allowed 1,5-sigmatropic hydrogen shift could also result in loss of the 
geometric or structural integrity of the dienes.  
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CHAPTER IV 
SYNTHESIS OF THE KEY SKELETON OF ANDRATINS (2) 
 
4.1 Revised Retrosynthetic Analysis of Andrastin C 
 
Having endured the failure that Diels-Alder substrate 70 could not undergo cyclization 
at all, I then turned to a revised synthetic route aiming at overcoming the drawbacks of 
substrate 70. My revised retrosynthetic analysis of andrastin C is described as 
highlighted in Scheme 16. 
Scheme 16. Revised retrosynthetic analysis of andrastin C 
 
I anticipated that an intramolecular Diels-Alder reaction of 73 would provide 
pentacyclic lactone 72, which contains the key skeleton of andrastin C. In my 
pre-conceived plan, the quaternary methyl group was omitted to minimize steric strain 
72
74
O
Wieland-Miescher ketone 
(15)
Me
O
Me
O
HO2C
42
75
76
andrastin C
O
Me
OH
Me
Me
H
MeMe
H
Me Me
CO2MeAcO
OMe
Me
HMe
H
Me Me
TBSO O
O
Me
Me
H
Me Me
TBSO O O
Me
O
73
Me
Me
H
Me Me
TBSO OH
Me
H
Me Me
TBSO
O
O
Me Me
TBSO
OO
Me
 27 
in the diene moiety of 73, which would be obtained by esterification of β-alcohol 74 
with carboxylic acid 42 corresponding to the D-ring fragment. β-Alcohol 74 could be 
deduced to the bicyclic diketone 75 through selective propenyl introduction followed by 
a diatereoselective reduction of the remained keto group. Diketone 75 would be 
constructed from 76 through an allylic oxidation and a reduction of the resultant enone. 
The decalin framework 76 can also be accessed from known Wieland-Miescher ketone 
15 via several transformations. Since the introduction of the quaternary methyl group on 
BC ring juncture would be possible by utilizing oxygen functionality on B ring, this 
synthetic strategy would enable the syntheses of andrastins and norandrastins via a 
pivotal synthetic intermediate as potential scaffold of andrastins.  
 
4.2 Synthesis of the trans-Fused AB Ring Fragment 82a 
 
Scheme 17. Preparation of enone 79 
 
Woodward methylation of 62 gave rise to 77 efficiently (Scheme 17).36 Reduction of 77 
with L-Selectride proceeded with high stereoselectivity to deliver the β-alcohol 78. 
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Protection of this hydroxyl group is necessary to facilitate the allylic oxidation 
programmed to follow. Formation of the TBS ether 76 in advance of exposure to the 
chromium trioxide/3,5-dimethylpyrazole complex is adequate to allow progression to 
79 in 73% overall yield.37 
 
Scheme 18. Kinetic versus thermodynamic hydrogenation 
 
Hydrogenation of alkenes toward the themodynamically favored configuration in 
complex molecule synthesis stands a great challenge when steric constraints of the 
substrate favor hydrogenation to a non-thermodynamic (kinetic) alkane product (see 
80→cis-81, Scheme 18). On the other hand, dissolving metal reduction provides a 
means to achieve thermodynamic control and can reduce conjugated38 or electron-poor 
alkenes39 at low temperature (see 80→trans-81). 
Table 4. Reduction of enone 79 
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conditions
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3
1
2
5
Metal
Na (10.0 eq)
Solvent Proton donor
t-BuOH (1.1 eq)NH3/THF
Yield (%)
44
Li (10.0 eq) NH3/Et2O t-BuOH (1.1 eq) 58
Na (10.0 eq) NH3/Et2O t-BuOH (1.1 eq) 73
Na (10.0 eq) NH3/Et2O H2O (1.1 eq) complex mixture
4 Na (10.0 eq) t-BuOH (2.0 eq)NH3/Et2O 39
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1 : 1
5 : 1
5 : 1
4 : 1
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As illustrated in Table 4, reduction of 79 both under the kinetic and thermodynamic 
conditions were tried. Unexpectedly, exposure of 79 with Pd/C delivered no products, 
and this may be due to the steric hindrance of the axial TBS ether and methyl groups 
preventing the approach of hydrogen and catalyst. Then, Li/NH3 was chosen as the 
reducing agent, and t-BuOH acted as the proton source to furnish the desired product 
82a and 82b in 58% total yield while in 1 : 1 diastereomeric ratio, the two diastereomer 
of 82a and 82b could be separated easily by column chromatography (entry 1). 
Gratifyingly, when changing the alkali metal from Li to Na (entry 2), both the yield and 
stereoselectivity could improve greatly to 73% and 5 : 1, respectively, with the 
trans-fused product 82a as the main product. When using THF as the co-solvent, 
although the stereoselectivty did not change, the yield decreased considerably to 44% 
(entry 3). When increasing the amount of proton donor t-BuOH from 1.1 eq to 2.0 eq, 
both the yield and the stereoselectivity declined due to the formation of the ketone 
over-reduced product (entry 4). In the case of H2O as the proton donor, the reaction only 
gave a complex mixture (entry 5). 
 
4.3 Preparation of the Diene Unit 74 
 
After having constructed the trans-fused AB ring fragment of andrastins, conditions of 
deprotection of the ketal moiety in 82a were screened (Scheme 19). Unexpectedly, 
under the acid condition of PTSA, PPTS or AcOH, none of them could afford the 
desired diketone 75 in acceptable yield. Then treatment of 82a with 1 M HCl solution 
furnished 75 in excellent yield, and no TBS deprotection by-product could be detected. 
The diketone 75 was allowed to react with relatively bulky i-BuOH in the presence of 
PTSA regioselectively to produce the iso-butyl enol ether 83 in 81% yield.   
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Scheme 19. Preparation of diene unit 74 
 
The product 83 was subjected to react with freshly prepared (E)-propenylmagnesium 
bromide followed by acidic hydrolysis to afford the dienone 84 in good yield. DIBAL 
reduction of 84 effectively gave the diastereomeric alcohol 74a and 74b in a ratio of ca. 
8 : 1, with the α-isomer 74b as the main product. The stereo-configuration of 74b was 
deduced by nOe correlations experiment as shown in Scheme 19 between Ha and 
protons Hb, Hc and Hd.  
Besides DIBAL, reduction of dienone 84 was also carried out under the conditions of 
L-Selectride, Al(Oi-Pr)3/i-PrOH, and CBS reagents wishing to increase the 
stereoselectivity to form the β-isomer 74a. Unfortunately, these conditions also 
predominantly gave the α-isomer, presumably because of the steric repulsion from the 
axial quaternary methyl group and the vicinal hydrogen, which preventing the approach 
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of hydride from the bottom face. As we know, secondary alcohol on an asymmetric 
center could undergo complete inversion of configuration under the Mitsunobu 
conditions, so chiral inversion of the hydroxyl group in 74b was examined. 
 
Scheme 20. Inversion of hydroxyl configuration in 74b 
 
The alcohol 74b and 4-nitrobenzoic acid were exposed to the Mitsunobu conditions, and 
the resulting p-nitrobenzoate 85 was proved to be so unstable that it could not be 
purified by chromatography. Actually, hydrolysis occurred to give the isomerized 
alcohol 86. Therefore, without any work-up process after the completion of the 
esterification, the reacting solution was directly subjected to LiAlH4 or 1 M NaOH. 
However, both the chiral inverted product 57a and isomerized alcohol 73 were also 
produced in this protocol (Scheme 20). 
 
4.4 Construction of the Key Skeleton of Andrastins 
 
With the diene 74b in hand, a dienophile cyclopentenone unit was introduced in the 
presence of DEAD and PPh3 to afford the configuration-inverted Diels-Alder precursor 
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73 (Scheme 21). Because of its instability, the precursor 73 was immediately subjected 
to the Diels-Alder reaction after a quick and simplified purification through a pad of 
silica gel. A heating of 73 in refluxing toluene in a sealed tube for 15 h furnished the 
desired Diels-Alder adduct 72 in 10% yield concomitant with 51% yield of the triene 
product 87 via a conjugative elimination of the ester group. The stereochemistries on 72 
were unambiguously determined by X-ray crystallography analysis (Figure 4), which 
suggests that the reaction proceeded via the endo transition state.  
 
Scheme 21. Construction of the key skeleton of andrastins 72 
 
Figure 4. ORTEP drawing of 72 
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This cycloaddition conducted under other thermal and Lewis acid conditions mainly 
gave the conjugative elimination product. 
The tendency toward such conjugated elimination of the ester group could be 
rationalized by the conformational restriction of the substrate. The ester group would be 
enforced in pseudoaxial position to overlap with the bonding π-orbital of the adjacent 
diene moiety, which is undesirable but ideal for the elimination process, by the rigid 
trans-decalin framework (Figure 5). In the previous synthesis of BCD ring fragment, 
the Diels-Alder precursor 53 would be free from such fixation of configuration. 
 
Figure 5. Supposed conformation of Diels-Alder reaction precursor 73 
 
Thus, I have applied intramolecular Diels-Alder approach to successfully construct the 
key skeleton of andrastins 72 in 12 steps from the optically active Wieland-Miescher 
ketone 15.  
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CONCLUSION 
 
Angularly cis-hydrindane has been constructed using the intramolecular Diels-Alder 
reaction which led to the preparation of CD, BCD, and ABCD fragment of andrastins. 
These results have underlied my synthetic strategy that Diels-Alder reaction provide an 
efficient means to form challenging cis-hydrindane. 
Especially, the highly functionalized pentacyclic lactone 72, a potential intermediate for 
the synthesis of the novel protein farnesyltransferase inhibitor andrastins, has been 
achieved from Wieland-Miescher ketone in 12 steps. Although the yield of the 
Diels-Alder reaction is relatively low, it has proved that intramolecular Diels-Alder 
strategy can act as a feasible means to achieve complex CD ring of andrastins. Since the 
72 is highly functionalized, further studies toward total synthesis or medicinal chemistry 
based on 72 could be performed. 
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EXPERIMENTAL 
All nonaqueous reactions were carried out under an Argon atmosphere. Reagents were 
purchased from commercial suppliers and used as received. Anhydrous solvents were 
prepared by distillation over CaH2, or purchased from commercial suppliers. 1H and 13C 
NMR spectra were recorded on a JEOL ECX 400 or a Varian GEMINI 300 instrument, 
Chemical shifts for 1H and 13C NMR spectra are reported in ppm (δ) relative to the 
residual 1H and 13C signals of the solvent (CDCl3: δ 7.26, 77.0 ppm) and the 
multiplicities are presented as follows: s = singlet, d = doublet, t = triplet, q = quartet, 
and m = multiplet. Mass spectra were measured on a JEOL JMS-GCmate II or a JEOL 
JMS-AX 505 HAD mass spectrometer, and the ionization method was electron impact 
(EI, 70 eV). IR spectra were recorded on a JASCO FT/IR-460Plus spectrometer. 
Column chromatography was carried out by employing Cica Silica Gel 60N (spherical, 
neutral, 40-50 µm). 
 
 
2,4,5-tribromo-3,6-dimethylphenol (24) To a flask was charged with Br2 (62.5 mL, 
1.22 mol), and then aluminum (2.5 g, 92.5 mmol) was added cautiously in small 
portions at 0 °C. The mixture was stirred at the same temperature for 2 h until the sparks 
ceased. A solution of 2,5-dimethylphenol 23 (25.0 g, 0.205 mol) in CH2Cl2 (62.5 mL) 
was added dropwise to the mixture over 2 h (the evolved HBr gas was trapped by an 
aqueous Na2CO3 solution). The solvent and excess bromine were removed in vacuo, the 
residue was stirred with 10% HCl (100 mL) for 4 h, then sodium thiosulfate was added 
OH
Me
Me
Br
Br
Br
24
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to decolorize the solution and filtered to give a yellow precipitate which can be further 
recrystallized from hot EtOH to give pure 24 (63.5 g, 88%) as white needles. 1H NMR 
spectrum of this phenol was identical with that reported.17 
1H NMR (300 MHz, CDCl3) δ 5.83 (1H, s), 2.66 (3H, s), 2.45 (3H, s). 
 
2,4,5-tribromo-3,6-dimethyl-4-nitrocyclohexa-2,5-dien-1-one (25) Fuming nitric acid 
(2.0 mL) was added rapidly to a cooled (10 °C) suspension of 24 (5.0 g, 13.9 mmol) in 
acetic acid (15 mL) and gave a red solution. After 15 min, crystallization was induced 
by the addition of a small piece of ice, and the 4-nitrodienone 25 (5.2 g, 93%) was 
yielded by filtration. 1H NMR spectrum of this dienone was identical with that 
reported.17 
1H NMR (300 MHz, CDCl3) δ 2.31 (3H, s), 2.21 (3H, s). 
 
2,5-dibromo-3,6-dimethylcyclohexa-2,5-diene-1,4-dione (26) The dienone 25 (2.2 g, 
5.45 mmol) was dissolved in carbon tetrachloride (10.0 mL), the solution was stirred at 
10 °C for 12 h, then concentrated, the residue was recrystallized by hexane/EtOAc (5 : 1) 
to the give benzoquinone 26 (0.64 g, 41%). 1H NMR spectrum of this benzoquinone 
was identical with that reported.17 
1H NMR (300 MHz, CDCl3) δ 2.30 (6H, s). 
O
Me
Me
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2-bromo-3,6-dimethyl-5-vinylcyclohexa-2,5-diene-1,4-dione (27) In a dry 50 mL 
round bottom flask benzoquinone 26 (0.55 g, 1.88 mmol) was dissolved in dioxane (10 
mL). Tributylvinyltin (0.55 mL, 1.88 mmol) was added, followed by Pd2(dba)3·CHCl3 
(25.3 mg, 24.4 µmol) and AsPh3 (43.2 mg, 0.14 mmol). The mixture was heated to 
reflux for 14 h then cooled and concentrated in vacuo. The crude product was purified 
by silica gel chromatography (eluent: hexane/AcOEt = 10 : 1) to afford pure 
benzoquinone 27 (0.4 g, 89%) as an orange solid. mp 98–99 °C. 
1H NMR (300 MHz, CDCl3) δ 6.59–6.50 (1H, m), 5.79 (1H, dd, J = 10.8, 2.8 Hz), 5.67 
(1H, dd, J = 10.8, 2.8 Hz), 2.17 (3H, s), 2.13 (3H, s); 13C NMR (75 MHz, CDCl3) δ 
187.1, 176.0, 157.5, 145.6, 144.3, 135.7, 130.3, 119.1, 19.0, 8.6; IR (KBr) 1659, 1647, 
1605 cm-1; HRMS (EI) calcd for C10H9BrO2 (M+) 239.9786, found 239.9795. 
 
(E)-2-bromo-3,6-dimethyl-5-styrylcyclohexa-2,5-diene-1,4-dione (31) In a dry 30 mL 
round bottom flask benzoquinone 26 (0.29 g, 1.0 mmol) was dissolved in dioxane (6 
mL). (E)-tributyl(styryl)tin (0.39 g, 1.0 mmol) was added, followed by Pd2(dba)3·CHCl3 
(13.5 mg, 13.0 µmol) and AsPh3 (23.0 mg, 75 µmol). The mixture was heated to reflux 
for 14 h then cooled and concentrated in vacuo. The crude product was purified by silica 
gel chromatography (eluent: hexane/AcOEt = 10 : 1) to afford pure benzoquinone 31 
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(0.28 g, 88%) as an orange solid. mp 121–122 °C. 
1H NMR (300 MHz, CDCl3) δ 7.54–7.33 (5H, m), 7.03 (1H, d, J = 16.5 Hz), 2.29 (3H, 
s), 2.27 (3H, s); 13C NMR (75 MHz, CDCl3) δ 189.2, 180.4, 159.5, 143.7, 143.3, 132.4, 
132.1, 128.6, 128.3, 127.9, 126.0, 125.4, 19.0, 8.6; IR (KBr) 1650, 1639, 1600 cm-1; 
HRMS (EI) calcd for C16H13BrO2 (M+) 316.0099, found 316.0080. 
 
(E)-1,3-dimethyl-2,5-dioxo-4-styrylcyclopent-3-ene-1-carbonitrile (32) In a 100 mL 
round bottom flask benzoquinone 31 (1.05 g, 3.3 mmol) was dissolved in 
methanol/CH2Cl2 (1 : 1) (50 mL). A solution of sodium azide (0.65 g, 10 mmol) in H2O 
(5 mL) was added and the reaction was heated to 50 °C for 12 h. After this time the 
mixture was diluted with Et2O and washed repeatedly with H2O, brine, dried over 
MgSO4, filtered, and concentrated in vacuo. The crude product was purified by silica 
gel chromatography (eluent: hexane/AcOEt = 10 : 1) to afford azidoquinone (0.62 g, 
67%) as a brown solid, which was used immediately. 
In a 100 mL round bottom flask, the above azidoquinone (0.62 g, 2.2 mmol) was 
dissolved in chlorobenzene (20 mL) and heated to reflux for 10 h. The reaction mixture 
was then cooled and concentrated in vacuo. The crude product was purified by silica gel 
chromatography (eluent: hexane/AcOEt = 8 : 1) to afford cyclopentenedione 32 (0.28 g, 
50%) as a yellow solid. mp 129–130 °C. 
1H NMR (300 MHz, CDCl3) δ 8.13 (1H, d, J = 16.2 Hz), 7.62–7.59 (2H, m), 7.45–7.42 
(3H, m), 7.01 (1H, d, J = 16.2 Hz), 2.26 (3H, s), 1.67 (3H, s); 13C NMR (75 MHz, 
CDCl3) δ 193.6, 193.5, 151.1, 148.0, 144.4, 135.6, 130.5, 129.0, 127.8, 115.4, 115.0, 
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44.9, 19.1, 9.8; IR (KBr) 2239, 1741, 1691, 1615, 1494, 1454 cm-1; HRMS (EI) calcd 
for C16H13NO2 (M+) 251.0946, found 251.0966. 
 
(E)-2,4-dimethyl-5-styrylcyclopent-4-ene-1,3-dione (33) The cyclopentenedione 32 
(32.4 mg, 0.13 mmol) was dissolved in concentrated HCl (2.0 mL). The solution was set 
to reflux for 10 h, then cooled to room temperature and poured into a mixture of 
saturated NaHCO3(aq) and ice. The solution was extracted with EtOAc (10 mL x 3), 
washed with brine, dried over MgSO4, filtered and concentrated in vacuo to give a 
yellow residue. The residue was purified by chromatography (eluent: hexane/AcOEt = 
8 : 1) over silica gel to give 33 (24 mg, 83%) as yellow crystal. mp 101–102 °C. 
1H NMR (300 MHz, CDCl3) δ 8.05 (1H, d, J = 16.2 Hz), 7.60–7.57 (2H, m), 7.43–7.35 
(3H, m), 7.00 (1H, d, J = 16.2 Hz), 2.77 (1H, q, J = 7.6 Hz), 2.18 (3H, s), 1.29 (3H, d, J 
= 7.6 Hz); 13C NMR (75 MHz, CDCl3) δ 203.1, 203.0, 151.3, 147.8, 141.5, 136.1, 129.4, 
128.6, 127.2, 116.2, 45.1, 10.4, 9.0; IR (KBr) 2969, 1728, 1685, 1615, 1348 cm-1; 
HRMS (EI) calcd for C15H14O2 (M+) 226.0994, found 226.0987. 
 
2-bromo-5-(furan-2-yl)-3,6-dimethylcyclohexa-2,5-diene-1,4-dione (35) In a dry 30 
mL round bottom flask benzoquinone 26 (0.59 g, 2.0 mmol) was dissolved in dioxane 
(11 mL). (2-Furyl)tributyltin (0.77 g, 2.1 mmol) was added, followed by 
Pd2(dba)3·CHCl3 (26.9 mg, 26.0 µmol) and AsPh3 (45.9 mg, 15 µmol). The mixture was 
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heated to reflux for 14 h then cooled and concentrated in vacuo. The crude product was 
purified by silica gel chromatography (eluent: hexane/AcOEt = 10 : 1) to afford 
benzoquinone 35 (0.54 g, 96%) as a brown solid. mp 113–115 °C. 
1H NMR (300 MHz, CDCl3) δ 7.54 (1H, d, J = 3.2 Hz), 7.04 (1H, d, J = 3.2 Hz), 6.50 
(1H, m), 2.43 (3H, s), 2.18 (3H, s), 2.18 (3H, s); 13C NMR (75 MHz, CDCl3) δ 187.2, 
186.0, 162.8, 160.3, 158.3, 156.7, 143.7, 135.2, 112.6, 109.4, 17.5, 9.8; IR (KBr) 1654, 
1631, 1605 cm-1; HRMS (EI) calcd for C12H9BrO3 (M+) 279.9735, found 279.9729. 
 
3-(furan-2-yl)-1,4-dimethyl-2,5-dioxocyclopent-3-ene-1-carbonitrile (36) In a 100 
mL round bottom flask benzoquinone 35 (0.46 g, 1.6 mmol) was dissolved in 
methanol/CH2Cl2 (1 : 1) (40 mL). A solution of sodium azide (0.21 g, 3.2 mmol) in H2O 
(4 mL) was added and the reaction was heated to 50 °C for 12 h. After this time the 
mixture was diluted with Et2O and washed repeatedly with H2O, brine, dried over 
MgSO4, filtered, and concentrated in vacuo to give the crude product. Purification by 
silica gel chromatography afforded azidoquinone (0.17 g, 43%) as a brown solid, which 
was used immediately. 
In a 30 mL round bottom flask, the above azidoquinone (0.17 g, 0.7 mmol) was 
dissolved in chlorobenzene (9 mL) and heated to reflux for 10 h. The reaction mixture 
was then cooled and concentrated in vacuo to give the crude product. Purification by 
silica gel chromatography afforded cyclopentenedione 36 (73 mg, 49%) as a yellow 
solid. mp 131–132 °C. 
1H NMR (300 MHz, CDCl3) δ 7.77 (1H, d, J = 1.9 Hz), 7.64 (1H, d, J = 3.6 Hz), 6.69 
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(1H, dd, J = 3.6, 1.9 Hz), 2.48 (3H, s), 1.67 (3H, s); 13C NMR (75 MHz, CDCl3) δ 193.5, 
191.5, 147.4, 147.4, 145.3, 139.7, 120.8, 114.8, 113.3, 44.6, 19.3, 11.0; IR (KBr) 2246, 
1747, 1696, 1609 cm-1; HRMS (EI) calcd for C12H9NO3 (M+) 215.0582, found 
215.0583. 
 
4-(furan-2-yl)-2,5-dimethylcyclopent-4-ene-1,3-dione (37) The cyclopentenedione 36 
(56 mg, 0.26 mmol) was dissolved in concentrated HCl (3.0 mL). The solution was set 
to reflux for 20 h, then cooled to 25 °C and poured into a mixture of NaHCO3(aq) and ice. 
The solution was extracted with EtOAc (5 mL x 3), washed with brine, dried over 
MgSO4, filtered and concentrated in vacuo. The residue was purified by flash column 
chromatography on silica gel (hexane/EtOAc = 10 : 1) to give 37 (15 mg, 30%) as 
yellow solid. mp 64–65 ºC. 
1H NMR (300 MHz, CDCl3) δ 7.69 (1H, d, J = 1.9 Hz), 7.56 (1H, d, J = 3.6 Hz), 6.62 
(1H, dd, J = 3.6, 1.9 Hz), 2.79 (1H, q, J = 6.6 Hz), 2.40 (3H, s), 1.30 (3H, d, J = 6.6 Hz); 
13C NMR (75 MHz, CDCl3) δ 203.4, 201.0, 146.4, 145.9, 140.0, 118.5, 112.7, 44.9, 
10.9, 10.3; IR (KBr) 2947, 1736, 1687, 1618 cm-1; HRMS (EI) calcd for C11H10O3 (M+) 
190.0630, found 190.0665 
 
3-ethoxy-2-methylcyclopent-2-en-1-one (39) To a stirred solution of 
2-methylcyclopentane-1,3-dione 38 (4.93 g, 44 mmol) in ethanol (88 mL) were added 
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ethyl orthoformate (32.1 mL, 176.2 mmol) and concentrated H2SO4 (2.45 mL, 44 
mmol) at room temperature. The reaction mixture was allowed to stir overnight, which 
was neutralized with saturated aqueous Na2CO3. Then the aqueous phase was extracted 
with CH2Cl2 (70 mL x 3), and the combined organic extracts were washed with brine, 
dried over Na2SO4, filtered, and concentrated in vacuo to ethyl enol ether 39 (5.8 g, 
94%) as a pale yellow oil. 1H NMR spectrum of this enone was identical with that 
reported.40  
1H NMR (300 MHz, CDCl3) δ 4.22 (2H, q, J = 6.9 Hz), 2.65–2.61 (2H, m), 2.44–2.41 
(2H, m), 1.63 (3H, s), 1.40 (3H, t, J = 6.9 Hz). 
 
3-(bis(methylthio)methyl)-2-methylcyclopent-2-en-1-one (40) To a stirred solution of 
bis(methylthio)methane (4.4 mL, 42.9 mmol) in THF (42.9 mL) at 0 °C was added 1.6 
M n-BuLi (26.8 mL, 42.9 mmol), maintained at this temperature for 30 minutes. Then 
the ethyl enol ether 39 (5.0 g, 35.7 mmol, neat) was cannulated to the solution of 
bis(methylthio)methyllithium (1 M in THF). After stirring at 0 °C for 5 h, the reaction 
mixture was added 10% aqueous HCl (20 mL) and extracted with EtOAc (50 mL x 3). 
The combined organic extracts were washed with brine and dried over Na2SO4. The 
solvent was removed in vacuo and the crude residue was purified by flash 
chromatography on silica gel (eluent: hexane/AcOEt = 5 : 1) to yield 40 (5.34 g, 74%) 
as a yellow oil. 1H NMR (400 MHz, CDCl3) δ 4.74 (1H, s), 2.69–2.66 (2H, m), 2.42–
2.39 (2H, m), 2.15 (6H, s), 1.73 (3H, t, J = 2.4 Hz); 13C NMR (100 MHz, CDCl3) δ 
209.5, 167.2, 136.6, 51.8, 33.9, 25.4, 15.5, 8.5; IR (neat) 2919, 1700, 737 cm-1; MS (EI) 
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m/z 202 (M+); HRMS (EI) calcd for C9H14OS2 (M+) 202.0486, found 202.0490. 
 
2-methyl-3-oxocyclopent-1-ene-1-carbaldehyde (41) Iodomethane (21 mL, 337 
mmol) and calcium carbonate (33.7 g, 337 mmol) were added to a solution of 40 (3.4 g, 
16.8 mmol) in a mixed solvent of acetonitrile (75 mL) and H2O (25 mL). After stirred at 
40 °C for 48 h, the reaction mixture was filtered and extracted with CH2Cl2 (50 mL x 3). 
The combined organic extracts were washed with brine and dried over Na2SO4. The 
solvent was removed in vacuo and the crude residue was purified by flash 
chromatography on silica gel (eluent: hexane/AcOEt = 3 : 1) to yield 41 (1.65 g, 79%) 
as a brown solid. mp 45–46 ºC. 
1H NMR (300 MHz, CDCl3) δ 10.4 (1H, s), 2.72–2.68 (2H, m), 2.52–2.48 (2H, m), 2.12 
(3H, s); 13C NMR (75 MHz, CDCl3) δ 210.7, 190.2, 158.4, 149.7, 34.0, 23.7, 8.4; IR 
(neat) 1709, 1679 cm-1; MS (EI) m/z 124 (M+); HRMS (EI) calcd for C7H8O2 (M+) 
124.0524, found 124.0517. 
 
2-methyl-3-oxocyclopent-1-ene-1-carboxylic acid (42) Compound 41 (1.3 g, 10.5 
mmol) was dissolved in a mixture of acetonitrile (50 mL) and 30% hydrogen peroxide 
(5.9 g) and stirred at room temperature. A solution of sodium chlorite (6.77 g, 52.4 
mmol) and sodium dihydrogen phosphate (8.18 g, 52.4 mmol) in water (30 mL) was 
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added dropwise over a period of 10 min. The reaction was stirred at room temperature 
for 2 h, acidified to pH 3 with 10% aqueous HCl and extracted with CH2Cl2 (30 mL x 8). 
The combined organic extracts were dried over Na2SO4, and the solvent was evaporated 
to give the carboxylic acid 42 (1.48 g, 98%) as a white solid. mp 181–182ºC. 
1H NMR (300 MHz, CDCl3) δ 2.81–2.79 (2H, m), 2.54–2.50 (2H, m), 2.10 (3H, s); 13C 
NMR (75 MHz, CDCl3) δ 209.7 170.4, 153.3, 34.2, 26.5, 10.3; IR (neat) 1719 cm-1; MS 
(EI) m/z 140 (M+); HRMS (EI) calcd for C7H8O3 (M+) 140.0473, found 140.0446. 
 
methyl 2-methyl-3-oxocyclopent-1-ene-1-carboxylate (43) To a solution of the 
carboxylic acid 42 (725 mg, 5.18 mmol) in a mixed solution of methanol (10 mL) and 
CH2Cl2 (10 mL), DMAP (316 mg, 2.59 mmol) and EDCI (1.5 g, 7.77 mmol) were 
added. The reaction mixture was allowed to stir 3 h at room temperature and 
concentrated in vacuo. The crude products were purified by flash chromatography on 
silica gel (eluent: hexane/AcOEt = 5 : 1) to give 43 (662 mg, 84%) as a colorless oil. 
The 1H and 13C NMR spectrum of this carboxylate was identical with that reported.41  
1H NMR (300 MHz, CDCl3) δ 3.86 (3H, s), 2.77–2.73 (2H, m), 2.48–2.45 (2H, m), 2.04 
(3H, t, J = 2.4 Hz); 13C NMR (75 MHz, CDCl3) δ 208.9, 165.3, 153.6, 146.8, 51.7, 33.5, 
26.1, 9.5. 
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(2E,4E)-hexa-2,4-dien-1-yl 2-methyl-3-oxocyclopent-1-ene-1-carboxylate (47) To a 
solution of the carboxylic acid 42 (440 mg, 3.14 mmol) in CH2Cl2 (15 mL), DMAP 
(192 mg, 1.57 mmol), EDCI (900 mg, 4.7 mmol), and 2,4-hexadien-1-ol (463 mg, 4.7 
mmol) were subsequently added. The reaction mixture was allowed to stir overnight and 
concentrated in vacuo. The crude products were purified by silica gel column 
chromatography (eluent: hexane/AcOEt = 10 : 1) to give 47 (581 mg, 84%) as a 
colorless oil. 
1H NMR (300 MHz, CDCl3) δ 6.35–6.27 (1H, m), 6.12–6.03 (1H, m), 5.84–5.63 (2H, 
m), 4.76 (2H, d, J = 6.9 Hz), 2.79–2.74 (2H, m), 2.48–2.45 (1H, m), 2.05 (3H, s), 1.77 
(3H, d, J = 6.6 Hz); 13C NMR (75 MHz, CDCl3) δ 209.3, 165.0, 154.1, 147.1, 135.4, 
131.6, 130.1, 122.8, 65.5, 33.8, 26.4, 18.1, 9.9; IR (neat) 2929, 1700, 1447 cm-1; MS (EI) 
m/z 220 (M+); HRMS (EI) calcd for C13H16O3 (M+) 220.1100, found 220.1095. 
 
(3aS,6R,6aR,9aR)-6,6a-dimethyl-3,3a,6,6a,8,9-hexahydro-1H,7H-indeno[3a,4-c]fur
an-1,7-dione (48) A solution of compound 47 (25 mg, 0.114 mmol) and BHT (2.5 mg, 
0.0114 mmol) in dry toluene (1.14 mL) was heated at 180 °C for 24 h in a sealed tube. 
After being cooled to room temperature, the tube was opened and the mixture was 
concentrated in vacuo. The crude products were purified by silica gel column 
chromatography (eluent: hexane/AcOEt = 2 : 1) to give 48 (23 mg, 91%) as a white 
crystal. mp 134–135 ºC. 
1H NMR (400 MHz, CDCl3) δ 5.89–5.86 (1H, m), 5.77–5.74 (1H, m), 4.51–4.48 (1H, 
m), 4.15–4.10 (1H, m), 3.11–3.05 (1H, m), 2.39–2.31 (1H, m), 2.16–2.01 (3H, m), 
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1.87–1.82 (1H, m), 1.21 (3H, s), 0.99 (3H, d, J = 7.8 Hz); 13C NMR (100 MHz, CDCl3) 
δ 217.0, 176.5, 136.5, 123.1, 67.6, 54.2, 52.3, 40.3, 39.9, 34.3, 23.1, 17.8, 17.1; IR 
(neat) 2978, 1757, 1734 cm-1; MS (EI) m/z 220 (M+); HRMS (EI) calcd for C13H16O3 
(M+) 220.1099, found 220.1092. 
 
3-isobutoxy-6,6-dimethylcyclohex-2-en-1-one (50) To a stirred solution of 
4,4-dimethylcyclohexane-1,3-dione 49 (5.0 g, 35.6 mmol) in cyclohexane (100 mL) was 
added PTSA (355 mg, 1.86 mmol) and isobutanol (6.7 mL, 72.5 mmol) at room 
temperature. After reflux with Dean-Stark apparatus for 5 h, the reaction mixture was 
diluted with Et2O and the reaction was quenched with saturated NaHCO3(aq). The water 
phase was extracted with Et2O (100 mL x 3) and the combined organic extracts were 
washed with brine, dried over MgSO4, filtered, and concentrated in vacuo. The residue 
was purified by flash column chromatography on silica gel (eluent: hexane/AcOEt = 3:1) 
to give the enol ether 50 (5.57 g, 80%) as a pale yellow oil.  
1H NMR (300 MHz, CDCl3) δ 5.23 (1H, s), 3.58 (2H, d, J = 6.6 Hz), 2.43 (2H, t, J = 5.8 
Hz), 2.17–2.15 (1H, m), 1.80 (2H, t, J = 6.3 Hz), 1.15 (6H, s), 0.98 (6H, d, J = 6.6 Hz); 
13C NMR (75 MHz, CDCl3) δ 204.2, 175.8, 100.8, 74.4, 39.9, 34.8, 27.5, 26.0, 24.4, 
18.9; IR (neat) 1655, 1611 cm-1; MS (EI) m/z 196 (M+); HRMS (EI) calcd for C12H20O2 
(M+) 196.1463, found 196.1463. 
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(E)-4,4-Dimethyl-3-(prop-1-en-1-yl)cyclohex-2-en-1-one (51) To a stirred suspension 
of Mg (604 mg, 24.9 mmol) in THF (48 mL) was added (E)-1-bromoprop-1-ene (2.1 
mL, 24 mmol) at room temperature and heated at reflux for 1.5 h. To a solution of the 
vinylogous ester 50 (201 mg, 1.02 mmol) in THF (10 mL) was added the above 
Grignard reagent (0.5 M in THF, 6.2 mL, 3.06 mmol) at 0 °C. After stirred for 80 min at 
room temperature, 10% aqueous HCl was added to the mixture at 0 °C. After stirred for 
5 min at the same temperature, the water phase was extracted with Et2O (30 mL x 3). 
The combined organic phases were washed with brine, dried over MgSO4, filtered, and 
and concentrated in vacuo. The residue was purified by flash column chromatography 
on silica gel (eluent: hexane/AcOEt = 5 : 1) to give the dienone 51 (112 mg, 66%) as a 
pale yellow oil.  
1H NMR (300 MHz, CDCl3) δ 6.28–6.08 (2H, m), 5.97 (1H, s), 2.43–2.38 (2H, m), 
1.85–1.81 (5H, m), 1.16 (6H, s); 13C NMR (75 MHz, CDCl3) δ 199.4, 166.3, 132.6, 
127.8, 121.5, 37.5, 34.6, 34.3, 26.8, 19.0; IR (neat) 1665 cm-1; MS (EI) m/z 164 (M+); 
HRMS (EI) calcd for C11H16O (M+) 164.1201, found 164.1203. 
 
(E)-4,4-dimethyl-3-(prop-1-en-1-yl)cyclohex-2-en-1-ol (52) To a stirred solution of 
the dienone 51 (51.7 mg, 0.314 mmol) in CH2Cl2 (2.0 mL) was added DIBAL (0.9 mL, 
0.9 mL) at 0 °C. After stirred for 15 min at the same temperature, the reaction was 
quenched with saturated aqueous NH4Cl at 0 °C. The filtrate was extracted with CH2Cl2 
(10 mL x 3), the combined organic phase was washed with brine, dried over Na2SO4, 
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filtered, and concentrated in vacuo. The residue was purified by flash column 
chromatography on silica gel (eluent: hexane/AcOEt = 2 : 1) to give the alcohol 52 
(50.2 mg, 96%) as a colorless oil.  
1H NMR (300 MHz, CDCl3) δ 5.96 (1H, s, J = 15.3 Hz), 5.89–5.80 (1H, m), 5.65 (1H, d, 
J = 3.3 Hz), 4.18 (1H, brs), 1.92–1.84 (1H, m), 1.74 (3H, d, J = 6.3 Hz), 1.60–1.38 (4H, 
m), 1.06 (3H, s), 1.00 (3H, s); 13C NMR (75 MHz, CDCl3) δ 147.0, 129.4, 126.1, 123.1, 
66.7, 35.6, 33.7, 29.0, 28.0, 27.8, 18.5; IR (neat) 3329 cm-1; MS (EI) m/z 166 (M+); 
HRMS (EI) calcd for C11H18O (M+) 166.1358, found 166.1380. 
 
(E)-4,4-dimethyl-3-(prop-1-en-1-yl)cyclohex-2-en-1-yl-2-methyl-3-oxocyclopent-1-e
ne-1-carboxylate (53) To a solution of carboxylic acid 42 (108 mg, 0.774 mmol) and 
alcohol 52 (82.7 mg, 0.497 mmol) in CH2Cl2 (5.0 mL) were added EDCI (195 mg, 1.02 
mmol) and DMAP (30.4 mg, 0.249 mmol) at room temperature. After stirred for 12 h at 
room temperature, the mixture was diluted with CH2Cl2 and the organic phase was 
washed with saturated NaHCO3(aq) and 10% aqueous citric acid, dried over MgSO4, 
filtered, and concentrated in vacuo. The residue was used immediately for the next 
reaction without further purification because of instability against column 
chromatography on silica gel.  
1H NMR (300 MHz, CDCl3) δ 5.96 (1H, s, J = 16.5 Hz), 5.93–5.82 (1H, m), 5.65 (1H, d, 
J = 3.8 Hz), 5.42 (1H, q, J = 4.7 Hz), 2.79–2.73 (2H, m), 2.47–2.44 (2H, m), 2.03 (3H, 
s), 2.00–1.92 (1H, m), 1.83–1.78 (1H, m), 1.75 (3H, d, J = 6.1 Hz), 1.71–1.63 (1H, m), 
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1.58–1.46 (1H, m), 1.10 (3H, s), 1.03 (3H, s); 13C NMR (75 MHz, CDCl3) δ 209.7, 
165.1, 154.9, 149.7, 128.8, 127.1, 117.6, 70.3, 35.1, 33.8, 33.5, 27.9, 27.3, 26.4, 25.1, 
18.4, 9.9; IR (neat) 1713, 1645, 1570 cm-1; MS (EI) m/z 288 (M+); HRMS (EI) calcd for 
C18H24O3 (M+) 288.1726, found 288.1753. 
 
(3aR,3a1S,5aS,10R,10aR)-8,8,10,10a-Tetramethyl-2,3,5a,6,7,8,10,10a-octahydro-4H
-cyclopenta[7,8]naphtho[1,8-bc]furan-1,4(3a1H)-dione (54a) 
(3aS,3a1S,5aS,10R,10aS)-8,8,10,10a-Tetramethyl-2,3,5a,6,7,8,10,10a-octahydro-4H-
cyclopenta[7,8]naphtho[1,8-bc]furan-1,4(3a1H)-dione (54b)  
A stainless sealed tube including a solution of the ester 53 (30.2 mg, 0.104 mmol) in 
xylene (0.9 mL) was heated at 145 °C for 18 h. After removal of the solvent in vacuo, 
the residue was purified by flash column chromatography on silica gel (eluent: 
hexane/AcOEt = 4 : 1) to give the lactones 54a (16.0 mg, 53%) as a colorless prism and 
54b (5.9 mg, 20%) as a pale yellow prism. 54a: mp 175–177 °C; 54b: mp 156–158 °C. 
54a: 1H NMR (300 MHz, CDCl3) δ 5.43 (1H, t, J = 2.5 Hz), 4.70–4.62 (1H, m), 3.14 
(1H, d, J = 8.5 Hz), 2.48–2.34 (1H, m), 2.15–1.99 (1H, m), 1.96–1.88 (4H, m), 1.64–
1.52 (3H, m), 1.20 (6H, s), 1.15 (3H, s), 1.01 (3H, d, J = 7.6 Hz); 13C NMR (75 MHz, 
CDCl3) δ 217.4, 176.6, 146.9, 128.2, 77.0, 56.4, 53.2, 43.0, 42.4, 36.4, 34.9, 33.6, 32.5, 
29.5, 29.4, 26.0, 18.0, 16.5; IR (KBr) 1761, 1734 cm-1; MS (EI) m/z 288 (M+); HRMS 
(EI) calcd for C11H18O (M+) 288.1726, found 288.1758. 
54b: 1H NMR (300 MHz, CDCl3) δ 5.47 (1H, t, J = 3.0 Hz), 4.72–4.65 (1H, m), 2.77–
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2.64 (2H, m), 2.49–2.27 (3H, m), 2.19–2.11 (1H, m), 2.08–2.01 (1H, m), 1.63–1.48 (2H, 
m), 1.35–1.29 (1H, m), 1.12 (6H, s), 1.01 (3H, s), 0.98 (3H, d, J = 7.1 Hz); 13C NMR 
(75 MHz, CDCl3) δ 216.0, 178.8, 138.8, 126.3, 76.7, 53.2, 52.6, 41.6, 34.6, 34.5, 33.2, 
31.4, 29.8, 28.8, 25.7, 16.6, 14.1; IR (KBr) 1750 cm-1; MS (EI) m/z 288 (M+); HRMS 
(EI) calcd for C11H18O (M+) 288.1726, found 288.1699. 
 
(R)-8a-methyl-3,4,8,8a-tetrahydronaphthalene-1,6(2H,7H)-dione (15) To a mixture 
of 2-methyl-1,3-dicyclohexanedione 60 (1.0 g, 7.93 mmol) and hydroquinone (8.5 mg, 
0.08 mmol) in distilled H2O was added methyl vinyl ketone (1.46 mL, 16.2 mmol). 
After the mixture has been stirred at 70–80 °C for 4 h, excess methyl vinyl ketone and 
H2O were removed in vacuo on a rotary evaporator to give the triketone 61 as a clear oil. 
The oil was dissolved in DMSO (4.5 mL), and unnatural D-(+)-proline (93.4 mg, 0.811 
mmol) was added. After the solution was degassed in vacuo for 4 d at room temperature, 
the mixture was poured into H2O (40 mL), and extracted several times with EtOAc. The 
combined organic layers were washed with water, brine, dried over Na2SO4, filtered, 
and evaporated under reduced pressure. The residue was purified by flash column 
chromatography on silica gel (hexane/EtOAc = 1 : 1) to give 15 (1.22 g, 87%) as a 
white solid. The above solid was then recrystallized from (Et2O/EtOAc = 10 : 1) to 
afford optically pure 15 (0.71 g). 1H and 13C NMR spectrum of 15 was identical with 
that reported.28  
1H NMR (400 MHz, CDCl3) δ 5.82 (1H, s), 2.73–2.64 (2H, m), 2.84–2.40 (4H, m), 
2.13–2.07 (3H, m), 1.75–1.64 (1H, m), 1.41 (3H, s); 13C NMR (100 MHz, CDCl3) δ 
O
Me
O
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211.0, 198.3, 165.8, 125.8, 50.6, 37.6, 33.6, 31.7, 29.6, 23.2, 22.9; IR 1708, 1665, 1615 
cm-1; [α]D20 –113.1 (c 1.13, CHCl3). 
 
(R)-8a-methyl-3,4,8,8a-tetrahydro-2H-spiro[naphthalene-1,2'-[1,3]dioxolan]-6(7H)-
one (62) The Wieland-Miescher ketone 15 (2.6 g, 14.6 mmol) was dissolved in ethylene 
glycol (70 mL), then PTSA (2.78 g, 14.6 mmol) was added. The resulting solution was 
stirred at room temperature for 23 min, after which it was poured carefully into a 
mixture of ice and saturated NaHCO3(aq). The solution was then extracted with EtOAc 
(50 mL x 4). The combined organic extracts were washed with water and brine, dried 
over Na2SO4, filtered, and evaporated under reduced pressure. The residue was purified 
by flash column chromatography on silica gel (hexane/EtOAc = 4 : 1) to give 62 (2.68 g, 
80%) as a white solid. mp 51–52 °C. 
1H NMR (400 MHz, CDCl3) δ 5.75 (1H, s), 3.92–3.87 (4H, m), 2.36–2.20 (5H, m), 
1.88–1.60 (5H, m), 1.30 (3H, s); 13C NMR (100 MHz, CDCl3) δ 199.1, 167.6, 125.5, 
112.3, 65.3, 65.0, 44.9, 33.8, 31.3, 29.9, 26.7, 21.6, 20.4; IR (KBr) 2948, 1670, 1619 
cm–1; HRMS (EI) calcd for C13H18O3 (M+) 222.1256, found 222.1289; [α]D20 –102.6 (c 
1.06, CHCl3). 
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(R)-8a-methyl-5-((phenylthio)methyl)-3,4,8,8a-tetrahydro-2H-spiro[naphthalene-1,
2'-[1,3]dioxolan]-6(7H)-one (63) A 100 mL round bottom flask, equipped with a reflux 
condenser, were charged with 62 (8.42 g, 37.9 mmol), thiophenol (5.8 mL, 56.8 mmoL), 
37 % aqueous formaldehyde solution (6.13 mL, 61.7 mmol), triethylamine (6.65 mL, 
47.7 mmol) and absolute ethanol (32 mL). The resulting mixture was heated at reflux 
for 4 d. The reaction mixture was cooled to room temperature, and was then treated with 
5% aqueous KOH solution (100 mL) and extracted with Et2O (40 mL x 3). The 
combined organic layers were washed with 5% aqueous KOH solution (20 mL x 3), 
dried over MgSO4 and concentrated in vacuo. The residue was purified by flash column 
chromatography on silica gel (hexane/EtOAc = 1 : 1) to give 63 (10.9 g, 84%) as a 
white solid. The 1H NMR data was in complete agreement with the reported values.30 
1H NMR (300 MHz, CDCl3) δ 7.41 (2H, d, J = 8.5 Hz), 7.38–7.17 (3H, m), 3.99–3.90 
(5H, m), 3.76 (1H, d, J = 11.5 Hz), 2,69–2.63 (1H, m), 2.53–1.61 (9H, m), 1.32 (3H, s).  
 
(4aR,8aR)-5,5,8a-trimethylhexahydro-2H-spiro[naphthalene-1,2'-[1,3]dioxolan]-6(
5H)-one (59) A 100 mL three-necked flask, equipped with a cold-finger condenser, was 
charged with liquid ammonia (50 mL) at –78 °C. Next, lithium metal wire (231 mg, 33 
mmol) was cut to small pieces, and were added to the vigorously stirred liquid ammonia, 
maintained dark blue for 15 min. A solution of 63 (1.14 g, 3.3 mmol) and H2O (119 µL, 
6.6 mmol) in THF (7.0 mL) was added to the Li/NH3 solution via a cannula. The 
reaction mixture was then allowed to stir vigorously for 45 min at –78 °C. Then MeI 
(3.08 mL, 49.5 mmol) in THF (7.0 mL) was added and stirred for 30 min at the same 
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temperature. Until the ammonia evaporated spontaneously at room temperature, the 
reaction mixture was extracted with EtOAc (50 mL x 3). The combined organic layers 
were washed with water, brine, dried over MgSO4 and concentrated in vacuo. The 
residue was purified by flash column chromatography on silica gel (hexane/EtOAc = 2 : 
1) to give 59 (694 mg, 83%) as a colorless solid. The 1H NMR data was in complete 
agreement with the reported values.31 
1H NMR (300 MHz, CDCl3) δ 3.95–3.79 (4H, m), 2.66–2.53 (1H, m), 2.34–2.26 (1H, 
m), 1.97–1.80 (2H, m), 1.70–1.60 (3H, m), 1.54–1.43 (4H, m), 1.21 (3H, s), 1.04 (3H, s), 
1.01 (3H, s); [α]D20 +36.7 (c 1.1, CHCl3). 
 
(4aR,6S,8aR)-5,5,8a-trimethyloctahydro-2H-spiro[naphthalene-1,2'-[1,3]dioxolan]-
6-ol (64) To a solution of 59 (2.53 g, 10.0 mmol) in THF (50 mL) at –78 °C, 1.0 M 
L-Selectride (100 mL, 100 mmol) was dropwise added and maintained at that 
temperature for 12 h. After the reaction had completed by TLC detection, it was 
quenched by 3.0 M aqueous NaOH solution (15 mL) and 30% H2O2 (15 mL), which 
was allowed to stir for 1 h at room temperature. The reaction solution was then 
extracted with EtOAc (50 mL x 4). The combined organic extracts were washed with 
brine, dried over Na2SO4, filtered, and evaporated under reduced pressure. The residue 
was purified by flash column chromatography on silica gel (hexane/EtOAc = 3 : 1) to 
give 64 (2.5 g, 98%) as a colorless oil. The 1H NMR data was in complete agreement 
with the reported values.32 
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1H NMR (300 MHz, CDCl3) δ 3.92–3.75 (4H, m), 3.32 (1H, s), 1.85–1.81 (1H, m), 
1.77–1.67 (1H, m), 1.63–1.07 (9H, m), 1.00 (3H, s), 0.89 (3H, s), 0.79 (3H, s); [α]D20 
+32.0 (c 1.02, CHCl3). 
 
(4aR,6S,8aR)-6-hydroxy-5,5,8a-trimethyloctahydronaphthalen-1(2H)-one (65) A 
solution of 64 (3.21 g, 12.6 mmol) in THF (55 mL) was treated with 1 M HCl (27.6 
mL), stirred at room temperature for 3 h, and then diluted with water. The aqueous 
phase was extracted with EtOAc (100 mL x 3) and the combined organic phases were 
washed with brine, dried, and evaporated. The residue was purified by flash column 
chromatography on silica gel (hexane/EtOAc = 3 : 1) afforded 65 (2.6 g, 99%) as a 
white solid. The 1H NMR data was in complete agreement with the reported values.32 
1H NMR (300 MHz, CDCl3) δ 3.40 (1H, s), 2.66–2.37 (1H, m), 2.22–2.15 (1H, m), 
2.05–1.89 (3H, m), 1.66–1.57 (4H, m), 1.38–1.32 (2H, m), 1.13 (3H, s), 0.96 (3H, s), 
0.92 (3H, s); [α]D20 +58.1 (c 1.01, CHCl3). 
 
(4aR,6S,8aR)-6-((tert-butyldimethylsilyl)oxy)-5,5,8a-trimethyloctahydronaphthalen
-1(2H)-one (66) To a stirred solution of 65 (1.58 g, 7.58 mmol) in DMF (56 mL) were 
added TBSCl (5.35 g, 35.5 mmol) and imidazole (2.58 g, 37.9 mmol). The mixture was  
stirred for 3 h at 90 °C, diluted with water and extracted with Et2O (50 mL x 3). The 
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combined organic extracts were washed with water and brine, dried over Na2SO4, 
filtered, and evaporated under reduced pressure. The residue was purified by flash 
column chromatography on silica gel (hexane/EtOAc = 20 : 1) to give 66 (2.15 g, 88%) 
as a colorless solid. The 1H NMR data was in complete agreement with the reported 
values.32 
1H NMR (300 MHz, CDCl3) δ 3.34–3.33 (1H, m), 2.59–2.48 (1H, m), 2.21–2.15 (1H, 
m), 2.07–1.97 (2H, m), 1.86–1.75 (1H, m), 1.63–1.47 (5H, m), 1.29–1.23 (1H, m), 1.12 
(3H, s), 0.90 (3H, s), 0.86 (3H, s), 0.86 (9H, s), 0.03 (3H, s), 0.00 (3H, s); [α]D20 +50.5 
(c 0.87, CHCl3). 
 
methyl(4aR,6S,8aR)-6-((tert-butyldimethylsilyl)oxy)-5,5,8a-trimethyl-1-oxodecahyd
ronaphthalene-2-carboxylate (58) To a solution of diisopropylamine (87.6 µL, 0.62 
mmol) in THF (3 mL) at 0 °C was added 0.39 mL of a 1.6 M solution of n-BuLi in 
hexane (0.62 mmol) and the mixture was stirred 30 min at the same temperature. Then 
cooling the solution to –78 °C, a solution of 66 (100 mg, 0.31 mmol) in THF (3 mL) 
was added via cannula needle. 30 min later, then NCCO2Me (37 µL, 0.465 mmol) was 
added, and allowed to react for 30 min, quenched with saturated NH4Cl(aq). EtOAc (5 
mL x 3) was used to extract the aqueous solution. The combined organic layers were 
washed with brine, dried over MgSO4 and concentrated in vacuo. The residue was 
purified by flash column chromatography on silica gel (hexane/EtOAc = 5 : 1) to give 
58 (109 mg, 92%) as a colorless oil. 
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1H NMR (300 MHz, CDCl3) δ 3.74 (3H, s), 3.68 (1H, dd, J = 13.2, 6.2 Hz), 3.35 (1H, s), 
2.21–2.16 (1H, m), 2.12–2.06 (1H, m), 2.01–1.93 (1H, m), 1.86–1.79 (1H, m),    
1.74–1.64 (3H, m), 1.57–1.52 (1H, m), 1.28–1.24 (1H, m), 1.18 (3H, s), 0.91 (3H, s), 
0.88 (3H, s), 0.87 (9H, s), 0.05 (3H, s), 0.03 (3H, s); 13C NMR (75 MHz, CDCl3) δ 
209.6, 171.2, 75.9, 52.9, 52.0, 49.0, 46.7, 39.2, 29.1, 29.0, 25.9, 25.7, 25.2, 22.3, 19.4, 
18.3, 18.2, –4.4, –5.0; IR (neat) 1747, 1710 cm–1; HRMS (EI) calcd for C21H38O4Si (M+) 
382.2539, found 382.2539; [α]D20 +24.8 (c 1.24, CHCl3). 
 
methyl(4aR,6S,8aR)-6-((tert-butyldimethylsilyl)oxy)-5,5,8a-trimethyl-1-(((trifluoro
methyl)sulfonyl)oxy)-3,4,4a,5,6,7,8,8a-octahydronaphthalene-2-carboxylate (67) A 
solution of 58 (1.62 g, 4.23 mmol) in THF (20 mL) was added dropwise to a suspension 
of NaH (60% dispersion in mineral oil, 220 mg, 5.5 mmol) in THF (20 mL) at 0 °C. The 
resulting suspension was stirred for 1.5 h at 0 °C, then cooled to –78 °C. Freshly 
distilled Tf2O (1.07 mL, 6.35 mmol) was added slowly to the above solution, and 
reacted for 1.5 h before the cold bath was removed, quenched with saturated NH4Cl(aq), 
and extracted with EtOAc (50 mL x 3). The combined organic layers were washed with 
brine, dried over MgSO4 and concentrated in vacuo. The residue was purified by flash 
column chromatography on silica gel (hexane/EtOAc = 10 : 1) to give 67 (2.17 g, 
quantitative) as a colorless oil. 
1H NMR (300 MHz, CDCl3) δ 3.76 (3H, s), 3.39 (1H, m), 2.63–2.58 (1H, m), 2.43–2.36 
(1H, m), 1.88–1.83 (2H, m), 1.76–1.68 (2H, m), 1.58–1.45 (3H, m), 1.19 (3H, s), 0.90 
(9H, s), 0.89 (3H, s), 0.86 (3H, s), 0.05 (3H, s), 0.04 (3H, s); 13C NMR (75 MHz, CDCl3) 
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δ 166.3, 157.1, 122.4, 120.8, 75.3, 52.2, 44.4, 39.8, 38.2, 29.0, 27.2, 27.0, 25.9, 25.4, 
21.9, 18.9, 18.2, 16.9, –4.4, –4.9; IR (neat) 1733, 1658, 1080 cm–1; HRMS (EI) calcd 
for C22H37O6F3SSi (M+) 514.2032, found 514.2025; [α]D20 +4.2 (c 1.09, CHCl3). 
 
methyl(4aS,6S,8aR)-6-((tert-butyldimethylsilyl)oxy)-5,5,8a-trimethyl-1-vinyl-3,4,4a,
5,6,7,8,8a-octahydronaphthalene-2-carboxylate (68) In a dry 50 mL round bottom 
flask triflate 67 (226 mg, 0.44 mmol) was dissolved in THF (12 mL) were added 
tributylvinyltin (200 µL, 0.66 mmol) and Pd(PPh3)4 (51 mg, 0.044 mmol). The mixture 
was heated to reflux for 36 hours then diluted with Et2O. The resulting solution was 
extracted with Et2O (10 mL x 3). The combined organic layers were washed with brine, 
dried over MgSO4 and concentrated in vacuo. The residue was purified by flash column 
chromatography on silica gel (hexane/EtOAc = 20 : 1) to give 68 (178 mg, quantitative) 
as a colorless oil. 
1H NMR (400 MHz, CDCl3) δ 6.36–6.28 (1H, m), 5.08 (1H, dd, J = 11.2, 2.4 Hz), 4.99 
(1H, dd, J = 17.6, 2.4 Hz), 3.63 (3H, s), 3.37 (1H, s), 2.44–2.37 (1H, m), 2.32–2.22 (1H, 
m), 1.91–1.82 (1H, m), 1.74–1.58 (3H, m), 1.53–1.45 (2H, m), 1.40–1.27 (1H, m), 1.04 
(3H, s), 0.89 (9H, s), 0.88 (3H, s), 0.83 (3H, s), 0.03 (3H, s), 0.02 (3H, s); 13C NMR 
(100 MHz, CDCl3) δ 171.9, 151.5, 135.2, 126.0, 117.5, 76.1, 43.2, 38.3, 37.7, 29.9, 29.0, 
27.8, 26.8, 26.0, 26.0, 22.0, 19.8, 17.5, 13.6, –4.4, –4.9; IR (neat) 1719, 1650 cm–1; 
HRMS (EI) calcd for C23H40O3Si (M+) 392.2747, found 392.2766; [α]D20 –33.5 (c 1.86, 
CHCl3). 
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((4aS,6S,8aR)-6-((tert-butyldimethylsilyl)oxy)-5,5,8a-trimethyl-1-vinyl-3,4,4a,5,6,7,
8,8a-octahydronaphthalen-2-yl)methanol (69) To a stirred solution of 68 (155 mg, 
0.395 mmol) in CH2Cl2 (8 mL) was added DIBAL (1.18 mL, 1.18 mmol) at 0 °C. After 
stirring for 30 min at the same temperature, then treated with saturated NH4Cl(aq). The 
reaction mixture was extracted EtOAc (10 mL x 3). The combined organic layers were 
washed with brine, dried over Na2SO4 and concentrated in vacuo. The residue was 
purified by flash column chromatography on silica gel (hexane/EtOAc = 5 : 1) to give 
69 as a white solid. mp 82–84 °C. 
1H NMR (400 MHz, CDCl3) δ 6.23–6.14 (1H, m), 5.24 (1H, dd, J = 11.2, 2.8 Hz), 4.96 
(1H, dd, J = 17.2, 2.8 Hz), 4.16 (1H, d, J = 11.2 Hz), 4.03 (1H, d, J = 11.2 Hz), 3.37 (1H, 
s), 2.37–2.30 (1H, m), 2.23–2.13 (1H, m), 1.90–1.82 (1H, m), 1.69–1.61 (3H, m), 1.50–
1.43 (2H, m), 1.34–1.24 (1H, m), 1.18 (1H, brs), 0.99 (3H, s), 0.89 (9H, s), 0.88 (3H, s), 
0.84 (3H, s), 0.03 (3H, s), 0.03 (3H, s); 13C NMR (100 MHz, CDCl3) δ 146.3, 134.3, 
130.0, 118.6, 76.2, 64.7, 43.9, 38.3, 37.5, 30.5, 29.1, 28.8, 26.2, 26.1, 22.2, 20.0, 18.3, 
18.1, –4.2, –4.7; IR (KBr) 3331, 1637 cm–1; HRMS (EI) calcd for C22H40O2Si (M+) 
364.2798, found 364.2797; [α]D20 –37.4 (c 1.46, CHCl3). 
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((4aS,6S,8aR)-6-((tert-butyldimethylsilyl)oxy)-5,5,8a-trimethyl-1-vinyl-3,4,4a,5,6,7,
8,8a-octahydronaphthalen-2-yl)methyl-2-methyl-3-oxocyclopent-1-ene-1-carboxyla
te (70) To a solution of the carboxylic acid 42 (17 mg, 0.123 mmol) in CH2Cl2 (2 mL), 
DMAP (2 mg, 0.0164 mmol), EDCI (24 mg, 0.123 mmol), and alcohol 69 (30 mg, 
0.082mmol) were subsequently added. The reaction mixture was allowed to stir 2 h and 
concentrated in vacuo. The residue was purified by flash column chromatography on 
silica gel (hexane/EtOAc = 5 : 1) to give 70 (36 mg, 90%) as a white solid. mp 69–
71 °C. 
1H NMR (400 MHz, CDCl3) δ 6.22–6.14 (1H, m), 5.26 (1H, dd, J = 10.8, 2.8 Hz), 4.95 
(1H, dd, J = 17.2, 2.8 Hz), 4.81–4.74 (2H, m), 3.37 (1H, s), 2.77–2.74 (2H, m), 2.47–
2.45 (2H, m), 2.25–2.16 (2H, m), 2.02 (3H, t, J = 2.4 Hz), 1.89–1.83 (1H, m), 1.71–1.62 
(3H, m), 1.52–1.44 (2H, m), 1.34–1.24 (1H, m), 1.00 (3H, s), 0.87 (9H, s), 0.87 (3H, s), 
0.84 (3H, s), 0.02 (3H, s), 0.02 (3H, s); 13C NMR (100 MHz, CDCl3) δ 210.1, 165.6, 
155.0, 149.7, 146.8, 133.8, 124.8, 119.5, 76.1, 67.4, 43.7, 38.3, 37.6, 33.8, 30.5, 29.1, 
29.0, 26.5, 26.0, 25.9, 22.0, 19.9, 18.2, 17.8, 9.7, –4.4, –4.9; IR (KBr) 1779, 1718 cm–1; 
HRMS (EI) calcd for C29H46O4Si (M+) 486.3165, found 486.3188; [α]D20 –11.8 (c 1.16, 
CHCl3). 
 
(R)-5,5,8a-trimethyl-3,7,8,8a-tetrahydro-2H-spiro[naphthalene-1,2'-[1,3]dioxolan]-
6(5H)-one (77) In an atmosphere of argon a solution of 62 (2.09 g, 9.4 mmol) dissolved 
in absolute tert-butanol (4.2 mL) was dropped in 5 min at 10 °C into a solution of 
potassium tert-butoxide (5.91 g, 52.7 mmol) in tert-butanol (63 mL). After having 
77
Me Me
O
OO
Me
 61 
vigorously stirred for 10 min at this temperature, methyl iodide (7.61 mL, 122.2 mmol) 
was added in 10 min while cooling with ice water. Then the reaction mixture was 
allowed to warm to room temperature for another 15 h, which was concentrated in 
vacuo. The residue was then diluted with water and extracted with Et2O (30 mL x 4). 
The combined organic extracts were washed with water and brine, dried over Na2SO4, 
filtered, and evaporated under reduced pressure. The residue was purified by flash 
column chromatography on silica gel (hexane/EtOAc = 3 : 1) to give 77 (1.88 g, 79%) 
as a colorless oil. 
1H NMR (400 MHz, CDCl3) δ 5.50 (1H, dd, J = 3.6, 3.6 Hz), 3.98–3.84 (4H, m), 2.54–
2.35 (2H, m), 2.22–2.14 (3H, m), 1.86–1.78 (1H, m), 1.66–1.57 (2H, m), 1.18 (6H, s), 
1.04 (3H, s); 13C NMR (100 MHz, CDCl3) δ 215.8, 147.3, 119.5, 111.9, 65.0, 64.7, 48.8, 
42.1, 34.0, 28.9, 27.0, 25.9, 24.6, 23.8, 23.4; IR (neat) 2972, 1709, 1143, 1038 cm–1; 
HRMS (EI) calcd for C15H22O3 (M+) 250.1569, found 250.1544; [α]D20 +11.7 (c 1.1, 
CHCl3). 
 
(6S,8aR)-5,5,8a-trimethyl-3,5,6,7,8,8a-hexahydro-2H-spiro[naphthalene-1,2'-[1,3]d
ioxolan]-6-ol (78) To a solution of 77 (11.0 g, 43.9 mmol) in THF at –78 °C, 1.0 M 
L-Selectride (100 mL, 100 mmol) was dropwise added and maintained at that 
temperature for 6 h. After the reaction had completed by TLC detection, it was 
quenched by 3.0 M aqueous NaOH solution (200 mL) and 30% H2O2 (200 mL), which 
was allowed to stir for 1 h at room temperature. The reaction solution was then 
extracted with CH2Cl2 (100 mL x 4). The combined organic extracts were washed with 
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brine, dried over Na2SO4, filtered, and evaporated under reduced pressure. The residue 
was purified by flash column chromatography on silica gel (hexane/EtOAc = 3 : 1) to 
give 78 (9.43 g, 85%) as a white solid. mp 60–62 °C. 
1H NMR (400 MHz, CDCl3) δ 5.50 (1H, s), 3.95–3.86 (4H, m), 3.42 (1H, s), 2.31–2.21 
(2H, m), 2.13–1.98 (3H, m), 1.92–1.84 (1H, m), 1.67–1.57 (3H, m), 1.30 (3H, s), 1.24–
1.20 (1H, m), 1.14 (3H, s), 1.12 (3H, s); 13C NMR (100 MHz, CDCl3) δ 145.4, 121.4, 
112.9, 76.4, 65.3, 64.8, 42.2, 40.7, 30.0, 27.8, 26.7, 25.9, 24.3, 24.2, 22.3; IR (KBr) 
3533, 2992, 1472, 1035 cm–1; HRMS (EI) calcd for C15H24O3 (M+) 252.1725, found 
252.1706; [α]D20 +75.2 (c 1.23, CHCl3). 
 
tert-butyldimethyl(((6S,8aR)-5,5,8a-trimethyl-3,5,6,7,8,8a-hexahydro-2H-spiro[nap
hthalene-1,2'-[1,3]dioxolan]-6-yl)oxy)silane (76) To a stirred solution of 78 (1.1 g, 
4.36 mmol) in DMF (40 mL) were added TBSCl (3.28 g, 21.8 mmol) and imidazole 
(1.48 g, 21.8 mmol) at room temperature. After stirring for 20 h at the same temperature, 
the reaction mixture was diluted with water and extracted with Et2O (50 mL x 3). The 
combined organic extracts were washed with water and brine, dried over Na2SO4, 
filtered, and evaporated under reduced pressure. The residue was purified by flash 
column chromatography on silica gel (hexane/EtOAc = 20 : 1) to give 76 (1.4 g, 88%) 
as a colorless oil. 
1H NMR (400 MHz, CDCl3) δ 5.36 (1H, dd, J = 3.6, 3.6 Hz), 3.95–3.85 (4H, m), 3.46 
(1H, dd, J = 4.4, 2.8 Hz), 2.28–2.03 (3H, m), 1.98–1.85 (2H, m), 1.59–1.47 (2H, m), 
1.25 (3H, s), 1.13–1.09 (1H, m), 1.06 (3H, s), 1.02 (3H, s), 0.86 (9H, s), 0.00 (3H, s), –
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0.01 (3H, s); 13C NMR (100 MHz, CDCl3) δ 147.4, 118.9, 113.4, 77.6, 65.6, 65.2, 42.7, 
41.0, 30.5, 28.5, 27.0, 26.8, 26.2, 25.8, 24.4, 23.0, 18.5, –4.1, –4.5; IR (neat) 2952, 1472, 
1252, 1089 cm–1; HRMS (EI) calcd for C21H38O3Si (M+) 366.2590, found 366.2636; 
[α]D20 +70.4 (c 1.15, CHCl3). 
 
(6S,8aR)-6-((tert-butyldimethylsilyl)oxy)-5,5,8a-trimethyl-6,7,8,8a-tetrahydro-2H-s
piro[naphthalene-1,2'-[1,3]dioxolan]-3(5H)-one (79) At 0 °C, a solution of CrO3 
(62.4 g, 624 mmol) dissolved in CH2Cl2 (500 mL) was added 3,5-dimethylpyrazone (60 
g, 624 mmol), stirred for 30 min. Then the solution of 76 (10.4 g, 28.4 mmol) in CH2Cl2 
(100 mL) was cannulated to the above prepared black mixture. After 5 h under stirring 
at room temperature, 3 M NaOH (800 mL) was added. The resulting mixture was 
extracted with CH2Cl2 (200 mL x 3). The extracts were washed with saturated 
NaHCO3(aq), water, dried and evaporated under reduced pressure. The residue was 
purified by flash column chromatography on silica gel (hexane/EtOAc = 10 : 1) to give 
79 (8.8 g, 82%) as a white solid. mp 113–114 °C. 
1H NMR (400 MHz, CDCl3) δ 5.97 (1H, s), 3.91–3.84 (4H, m), 3.54 (1H, dd, J = 4.4 Hz, 
2.8 Hz), 2.78 (1H, d, J = 17.2 Hz), 2.51 (1H, d, J = 17.2 Hz), 2.38–2.30 (1H, m), 2.07–
1.98 (1H, m), 1.63–1.56 (1H, m), 1.41 (3H, s), 1.26–1.21 (1H, m), 1.43 (3H, s), 1.13 
(3H, s), 0.84 (9H, s), 0.01 (3H, s), 0.00 (3H, s); 13C NMR (100 MHz, CDCl3) δ 197.8, 
176.0, 124.6, 113.0, 76.1, 65.6, 65.2, 44.5, 44.2, 42.5, 29.3, 27.6, 25.7, 25.5, 24.8, 22.4, 
18.0, –4.5, –4.9; IR (KBr) 2956, 1662, 1091 cm–1; HRMS (EI) calcd for C21H36O4Si 
(M+) 380.2383, found 380.2387; [α]D20 +16.9 (c 1.60, CHCl3). 
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(4aR,6S,8aR)-6-((tert-butyldimethylsilyl)oxy)-5,5,8a-trimethylhexahydro-2H-spiro[
naphthalene-1,2'-[1,3]dioxolan]-3(4H)-one (82a)   
(4aS,6S,8aR)-6-((tert-butyldimethylsilyl)oxy)-5,5,8a-trimethylhexahydro-2H-spiro[
naphthalene-1,2'-[1,3]dioxolan]-3(4H)-one (82b) 
Sodium (460 mg, 20 mmol) was added to liquid ammonia (100 mL) while cooling in a 
liquid nitrogen–acetone bath. After 0.5 h, a solution of 79 (760 mg, 2.0 mmol) and 
tert-butanol (210 µL, 2.2 mmol) in dry Et2O (30 mL) was introduced. Increasing the 
temperature to –35 °C, and maintained for 0.5 h at that temperature before being 
quenched with solid NH4Cl. After evaporation of the ammonia gas, the resultant slurry 
was treated with water (50 mL) and EtOAc (50 mL), and the precipitate was filtered 
through Celite and washed thoroughly. The filtrate was extracted with EtOAc (50 mL x 
3). The extracts were washed with water and brine, dried over Na2SO4, filtered, and 
evaporated under reduced pressure. The residue was purified by flash column 
chromatography on silica gel (hexane/EtOAc = 20 : 1) afforded the 82a (460 mg, 60%, 
colorless oil) and 82b (100 mg, 13%, colorless oil). 
82a: 1H NMR (400 MHz, CDCl3) δ 3.96–3.83 (4H, m), 3.39 (1H, brs), 2.67 (1H, d, J = 
15.2 Hz), 2.43–2.19 (4H, m), 2.06–1.99 (1H, m), 1.88–1.80 (1H, m), 1.52–1.46 (1H, m), 
1.18–1.12 (4H, m), 0.87 (9H, s), 0.84 (3H, s), 0.82 (3H, s), 0.02 (3H, s), –0.01 (3H, s); 
13C NMR (100 MHz, CDCl3) δ 208.8, 113.6, 76.2, 65.5, 48.5, 42.4, 38.8, 38.3, 38.3, 
28.8, 25.8, 25.3, 23.3, 21.2, 18.1, 16.5, –4.5, –4.8; IR (neat) 2957, 1712, 1257, 1156, 
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1075 cm–1; HRMS (EI) calcd for C17H29O4Si (M+–57) 325.1835, found 325.1793; 
[α]D20 +45.2 (c 1.65, CHCl3). 
82b: 1H NMR (400 MHz, CDCl3) δ 4.01–3.91 (4H, m), 3.42 (1H, dd, J = 5.6, 3.2 Hz), 
3.10–3.03 (1H, m), 2.76–2.71 (1H, m), 2.50–2.44 (1H, m), 2.11–2.04 (1H, m), 1.90–
1.82 (1H, m), 1.73–1.64 (2H, m), 1.36–1.30 (1H, m), 1.18 (3H, s), 1.05 (3H, s), 0.93 
(3H, s), 0.87 (9H, s), 0.04 (3H, s), 0.03 (3H, s); 13C NMR (100 MHz, CDCl3) δ 208.9, 
114.3, 76.5, 65.3, 64.7, 48.3, 46.5, 42.1, 42.1, 38.8, 30.4, 27.2, 25.9, 24.8, 23.6, 18.0, –
4.4, –5.0; IR (neat) 2954, 1717, 1252, 1074 cm–1; HRMS (EI) calcd for C21H38O4Si (M+) 
382.2539, found 382.2528; [α]D20 +119.2 (c 0.58, CHCl3). 
 
(4aR,6S,8aR)-6-((tert-butyldimethylsilyl)oxy)-5,5,8a-trimethylhexahydro-2H-spiro[
naphthalene-1,2'-[1,3]dioxolan]-3(4H)-one (75) A solution of 82a (5.02 g, 13.1 mmol) 
in THF (600 mL) was treated with 1 M HCl (65.6 mL), heated to 60 °C for 20 h, and 
diluted with water. The aqueous phase was extracted with EtOAc (200 mL x 3) and the 
combined organic phases were washed with brine, dried, and evaporated. 
Chromatography of the residue on silica gel (hexane/EtOAc = 3 : 1) afforded 75 (4.3 g, 
97%) as a white solid. mp 205–207 °C. 
1H NMR (400 MHz, CDCl3) δ 3.48–3.32 (3H, m), 2.54 (1H, d, J = 9.6 Hz), 2.07–1.98 
(2H, m), 1.91–1.83 (1H, m), 1.61–1.51 (2H, m), 1.16 (3H, s), 0.93 (3H, s), 0.90 (3H, s), 
0.85 (9H, s), 0.04 (3H, s), 0.01 (3H, s); 13C NMR (100 MHz, CDCl3) δ 208.3, 205.2, 
75.7, 54.5, 47.1, 38.9, 38.2, 37.6, 28.6, 26.1, 25.9, 24.9, 21.8, 18.1, 17.4, –4.4, –4.9; IR 
75
H
Me Me
TBSO O
O
Me
 66 
(KBr) 2951, 1610, 1530, 1473, 1313, 1225 cm–1; HRMS (EI) calcd for C19H34O3Si (M+) 
338.2277, found 338.2274; [α]D20 +54.3 (c 0.90, CHCl3). 
 
(4aR,6S,8aR)-6-((tert-butyldimethylsilyl)oxy)-3-isobutoxy-5,5,8a-trimethyl-4a,5,6,7,
8,8a-hexahydronaphthalen-1(4H)-one (83) A 500 mL round flask equipped with 
Dean-Stark apparatus was charged with 75 (3.23 g, 9.56 mmol) and cyclohexane (134 
mL), then isobutanol (20 mL) and PTSA (0.91 g, 4.78 mmol) were added. The resulting 
mixture was refluxed for 1.5 h, and then quenched with triethylamine. The reaction 
mixture was extracted with EtOAc (100 mL x 3). The combined organic layers were 
washed with brine, dried over Na2SO4 and concentrated in vacuo. The residue was 
purified by flash column chromatography on silica gel (hexane/EtOAc = 6 : 1) to give 
83 (3.13 g, 83%) as a colorless oil. 
1H NMR (400 MHz, CDCl3) δ 5.15 (1H, d, J = 1.6 Hz), 3.59–3.51 (2H, m), 3.38 (1H, d, 
J = 2.4 Hz), 2.42–2.34 (1H, m), 2.22 (1H, dd, J = 17.2, 4.4 Hz), 2.10 (1H, dd, J = 13.2, 
4.4 Hz), 2.03–1.96 (1H, m), 1.85–1.82 (2H, m), 1.59–1.53 (2H, m), 1.04 (3H, s), 0.97–
0.94 (9H, m), 0.89 (3H, s), 0.84 (9H, s), 0.02 (3H, s), 0.01 (3H, s); 13C NMR (100 MHz, 
CDCl3) δ 206.0, 176.4, 100.2, 76.0, 74.6, 44.0, 41.4, 38.5, 28.4, 27.8, 27.0, 26.1, 25.9, 
25.3, 22.2, 19.1, 19.1, 18.1, 18.1, 17.9, –4.4, –5.0; IR (neat) 2956, 1659, 1616, 1206, 
1075 cm–1; HRMS (EI) calcd for C23H42O3Si (M+) 394.2903, found 394.2942; [α]D20 
+77.5 (c 2.80, CHCl3). 
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(4aR,7S,8aS)-7-((tert-butyldimethylsilyl)oxy)-4a,8,8-trimethyl-4-((E)-prop-1-en-1-yl
)-4a,5,6,7,8,8a-hexahydronaphthalen-2(1H)-one (84) A solution of 83 (346 mg, 0.88 
mmol) in dry THF (5 mL) was treated at 0 °C with (E)-prop-1-en-1-ylmagnesium 
bromide (3.5 mL, 3.5 mmol) which was freshly prepared from (E)-1-bromoprop-1-ene. 
After 2 h under stirring at room temperature, 10% HCl was added. The resulting 
mixture was extracted with EtOAc (20 mL x 3). The combined organic extracts were 
washed with water and brine, dried over Na2SO4 and evaporated under reduced pressure. 
The residue was purified by flash column chromatography on silica gel (hexane/EtOAc 
= 10 : 1) to give 84 (235 mg, 74%) as a colorless oil. 
1H NMR (400 MHz, CDCl3) δ 6.17–6.14 (2H, m), 5.89 (1H, s), 3.40 (1H, s), 2.33–2.20 
(3H, m), 2.02–1.88 (1H, m), 1.82–1.77 (4H, m), 1.58–1.51 (2H, m), 1.10 (3H, s), 0.90 
(3H, m), 0.85 (9H, s), 0.85 (3H, s), 0.03 (3H, s), 0.01 (3H, s); 13C NMR (100 MHz, 
CDCl3) δ 201.0, 170.3, 132.9, 126.9, 121.1, 75.4, 43.4, 38.7, 38.1, 34.7, 29.0, 28.5, 25.9, 
25.7, 21.5, 18.9, 18.8, 18.1, –4.4, –5.0; IR (neat) 2955, 1663, 1256, 1076 cm–1; HRMS 
(EI) calcd for C22H38O2Si (M+) 362.2641, found 362.2617; [α]D20 –29.5 (c 1.15, 
CHCl3). 
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(2S,4aR,7S,8aS)-7-((tert-butyldimethylsilyl)oxy)-4a,8,8-trimethyl-4-((E)-prop-1-en-
1-yl)-1,2,4a,5,6,7,8,8a-octahydronaphthalen-2-ol (74a)  
(2R,4aR,7S,8aS)-7-((tert-butyldimethylsilyl)oxy)-4a,8,8-trimethyl-4-((E)-prop-1-en-
1-yl)-1,2,4a,5,6,7,8,8a-octahydronaphthalen-2-ol (74b)  
To a stirred solution of 84 (200 mg, 0.55 mmol) in CH2Cl2 (40 mL) was added DIBAL 
(1.66 mL, 1.66 mmol) at 0 °C. After stirring for 15 min at the same temperature, the 
reaction mixture was treated with saturated NH4Cl aqueous solution (2 mL). The 
reaction mixture was extracted with EtOAc (20 mL x 3). The combined organic layers 
were washed with brine, dried over Na2SO4 and concentrated in vacuo. The residue was 
purified by flash column chromatography on silica gel (hexane/EtOAc = 20 : 1) to give 
74a (18 mg, 9%, colorless oil) and 74b (159 mg, 79%, colorless oil). 
74a: 1H NMR (400 MHz, CDCl3) δ 5.99 (1H, d, J = 15.2 Hz), 5.86–5.77 (1H, m), 5.59 
(1H, d, J = 4.8 Hz), 4.16 (1H, s), 3.41 (1H, dd, J = 2.8, 2.8 Hz), 1.94–1.82 (2H, m), 
1.75–1.63 (6H, m), 1.54–1.40 (3H, m), 0.95 (3H, s), 0.90 (3H, m), 0.89 (9H, s), 0.85 
(3H, s), 0.04 (3H, s), 0.04 (3H, s); 13C NMR (100 MHz, CDCl3) δ 152.1, 128.6, 127.1, 
120.6, 76.2, 65.2, 38.7, 37.9, 37.9, 29.8, 29.1, 27.9, 26.1, 26.0, 22.0, 18.9, 18.4, 18.2, –
4.3, –4.8; IR (neat) 3427, 2956, 1256, 1081, 1020 cm–1; HRMS (EI) calcd for 
C22H40O2Si (M+) 364.2798, found 364.2796; [α]D20 +20.4 (c 0.81, CHCl3). 
74b: 1H NMR (400 MHz, CDCl3) δ 5.93 (1H, d, J = 16.0 Hz), 5.85–5.76 (1H, m), 5.46 
(1H, s), 4.27 (1H, t, J = 8.4 Hz), 3.37 (1H, dd, J = 2.8, 2.8 Hz), 1.96–1.87 (2H, m), 
1.73–1.67 (4H, m), 1.63–1.55 (2H, m), 1.51–1.29 (3H, m), 1.06 (3H, s), 0.88 (9H, s), 
0.86 (3H, s), 0.85 (3H, s), 0.03 (3H, s), 0.02 (3H, s); 13C NMR (100 MHz, CDCl3) δ 
150.0, 128.5, 126.4, 122.8, 75.8, 69.8, 43.1, 37.9, 37.7, 29.9, 29.0, 28.8, 26.0, 25.9, 22.0, 
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20.6, 18.4, 18.2, –4.4, –4.9; IR (neat) 3298, 2957, 1257, 1078, 1015 cm–1; HRMS (EI) 
calcd for C22H40O2Si (M+) 364.2798, found 364.2795; [α]D20 +11.6 (c 0.58, CHCl3). 
 
1-((4aS,6S,8aR,E)-6-((tert-butyldimethylsilyl)oxy)-5,5,8a-trimethyl-4a,5,6,7,8,8a-he
xahydronaphthalen-1(4H)-ylidene)propan-2-ol (86) To a solution of the alcohol 74b 
(12.0 mg, 0.033 mmol) and 4-nitrobenzoic acid (22 mg, 0.131 mmol) in THF (2 mL) 
were added PPh3 (39.3 mg, 0.15 mmol) and diethyl azodicarboxylate (26 µL, 0.131 
mmol) at 0 °C, then stirred for 10 h at room temperature. 1 M NaOH (0.49 mL) in 
methanol (0.5 mL) was added to the above resulting mixture, and stirred for another 24 
h. The reacted solution was extracted with CH2Cl2 (10 mL x 3), the extracts were 
washed with saturated NaHCO3(aq), water, dried and concentrated in vacuo. The residue 
was purified by flash column chromatography on silica gel (hexane/EtOAc = 10 : 1) to 
give 74a (5.2 mg, 43%) and 86 (6.8 mg, 56%, colorless oil). 
86: 1H NMR (300 MHz, CDCl3) δ 6.32 (1H, d, J = 10.2 Hz), 5.88–5.83 (1H, m), 5.21 
(1H, d, J = 8.5 Hz), 4.79–4.70 (1H, m), 3.39 (1H, d, J = 3.8 Hz), 2.09–2.05 (2H, m), 
1.94–1.90 (2H, m), 1.77–1.74 (1H, m), 1.58–1.42 (2H, m), 1.25 (3H, d, J = 6.2 Hz), 
0.99 (3H, s), 0.91 (3H, s), 0.89 (9H, s), 0.85 (3H, s), 0.05 (3H, s), 0.02 (3H, s); 13C 
NMR (75 MHz, CDCl3) δ 151.9, 126.9, 124.6, 122.8, 87.1, 65.7, 46.4, 39.2, 38.3, 30.0, 
28.6, 28.2, 25.9, 25.8, 23.6, 20.5, 18.4, 18.1, –4.3, –4.8; IR (neat) 3324, 2956, 1278, 
1044 cm–1; HRMS (EI) calcd for C22H40O2Si (M+) 364.2798, found 364.2795; [α]D20 
+64.7 (c 0.44, CHCl3). 
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(3aR,3a1S,5aS,6aS,8S,10aR,12R,12aR)-8-((tert-butyldimethylsilyl)oxy)-7,7,10a,12,12
a-pentamethyl-2,3,5a,6,6a,7,8,9,10,10a,12,12a-dodecahydro-4H-cyclopenta[1,2]phe
nanthro[10,1-bc]furan-1,4(3a1H)-dione (72) 
(((2S,4aR,8aS,E)-5-allylidene-1,1,4a-trimethyl-1,2,3,4,4a,5,8,8a-octahydronaphthal
en-2-yl)oxy)(tert-butyl)dimethylsilane (87) 
To a solution of the alcohol 74b (18.2 mg, 0.05 mmol) in THF (1 mL) were added PPh3 
(39.3 mg, 0.15 mmol) and diethyl azodicarboxylate (28 mg, 0.16 mmol) at 0 °C. Then 
carboxylic acid 42 (8.4 mg, 0.06 mmol) was added to the above mixture and stirred for 
1 h at room temperature. The resulting mixture was extracted with CH2Cl2 (10 mL x 3). 
The extracts were washed with saturated NaHCO3(aq), water, dried and evaporated under 
reduced pressure to give a brown oil, which was dissolved in toluene (0.5 mL) in a 
sealed tube and heated to reflux for 15 h. The resulting solution was concentrated in 
vacuo, the residue was purified by flash column chromatography on silica gel 
(hexane/EtOAc = 3 : 1) to give 72 (2.4 mg, 10%, white solid) and 87 (8.7 mg, 50%, 
colorless oil). 
72: 1H NMR (400 MHz, CDCl3) δ 5.16 (1H, brs), 5.07–5.02 (1H, m), 3.44 (1H, m), 
3.20–3.19 (1H, m), 2.47–2.20 (1H, m), 2.16–2.03 (3H, m), 2.00–1.88 (3H, m), 1.79–
1.66 (2H, m), 1.39–1.34 (1H, m), 1.26–1.24 (1H, m), 1.21 (3H, s), 1.01 (3H, d, J = 7.6 
Hz), 1.00 (3H, s), 0.89 (3H, s), 0.82 (9H, s), 0.81 (3H, s), 0.03 (3H, s), 0.01 (3H, s). 
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87: 1H NMR (400 MHz, CDCl3) δ 6.83–6.74 (1H, m), 6.53 (1H, d, J = 9.2 Hz), 5.88 
(2H, d, J = 10.0 Hz), 5.18 (1H, dd, J = 16.8, 2.0 Hz), 5.06 (1H, dd, J = 10.0, 2.0 Hz), 
3.40 (1H, d, J = 4.0 Hz), 2.15–2.03 (2H, m), 1.98–1.89 (2H, m), 1.81–1.77 (2H, m), 
1.59–1.52 (2H, m), 1.00 (3H, s), 0.92 (3H, s), 0.88 (9H, s), 0.87 (3H, s), 0.05 (3H, s), 
0.02 (3H, s); 13C NMR (100 MHz, CDCl3) δ 148.9, 133.0, 129.7, 122.7, 120.4, 115.8, 
76.4, 42.1, 38.3, 37.4, 29.4, 28.9, 26.0, 25.9, 23.9, 22.4, 21.2, 18.2, –4.3, –4.9; IR (neat) 
2956, 1472, 1256, 1078 cm–1; HRMS (EI) calcd for C22H38OSi (M+) 346.2692, found 
346.2689; [α]D20 +817.6 (c 0.42, CHCl3). 
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